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PREAMBLE 
V I I I 
The nrdB gene of bacteriophage T4 contains 598 base-pair self-splic-
ing intron. Several studies revealed that this intron is closely related to the 
group I type introns of eukaryotic organelles, such as mitochondria, 
chloroplast, and nucleus (Gott et al, 1986; Sjoberg et al, 1986; Cech, 1988). 
Autocatalysis of these introns is achieved by folding of the intron into a 
characteristic secondary structure necessary for intron excision and exon 
ligation ( Belfort, 1990; Cech, 1990 Wittop-koning and Schumperii, 1994). 
Basic features of the predicted three dimensional tertiary structure have 
been characterized by mutant analysis in vitro and by the use of specifically 
positioned photochemical cross linking, affinity cleavage reagents as well 
as by studies with enzymatic methods, chemical probe, NMR spectroscopy 
and computer algorithms (Allain and Varani, 1995; Gultyaev et al, 1995). 
The T4 introns are capable of self-splicing and contain the conserved 
structural features folded into a common secondary structure of group I 
type introns (Hall et al, 1987; Heuer et al, 1991). To examine the predicted 
secondary and tertiary structure of group I type introns, random mutagenesis 
utilizing novel technique with T4 are very useful. One such approach with 
T4 is based on a phenotype screening method (Lai and Hall, 1993). The 
advantage of this technique is the easy mapping of mutations due to the 
promiscuous recombination system of T4. 
The action of group I type introns of T4 phage was found to be similar 
as that of ribozymes (Cech, 1987; Michel and Westhof, 1990) which have 
gained tremendous popularity during the recent years due to their diversi-
fied types of applications in medicine ( Sarver et al, 1990; Dropulic et al, 
IX 
1992; Koizumui et al, 1995). 
We have therefore, selected bacteriophage T4 system which provides 
a convenient model for studying both the genetic and functional aspects of 
splicing and the major objectives of the present investigation v^ e^re, (1) to 
study structural functional relationship of nrdB intron of the gene coding for 
small subunit of ribonucleotide reductase of bacteriophage T4 by isolating 
splicing defective point mutations, and (2) to study the secondary and terti-
ary structures of group I self-splicing intron of nrdB gene by isolating intra-
and extra-genic second site revertants of previously characterized frdl dou-
ble mutants. 
In the first chapter of the thesis, we have presented the literature 
relevent to the RNA splicing with special reference to group I introns and 
their special features along with the scope of the work, in view of the po-
tential utility of ribozymes to introduce with the subject. 
The second chapter describes general methodological aspects and 
working chemicals , bacterial and phage strains, etc. employed during the 
course of investigations. 
The isolation and characterization of splicing defective point mutations 
within the nrdB intron of T4 phage have been described in third chapter. 
Fourth chapter deals with the study of some intragenic and extragenic 
revertants of frd^nrdB double mutants of T4 phage. 
General discussion and conclusions drawn from the experimental data 
have been presented in fifth chapter. The purpose of the general discus-
sion is to coordinate very briefly the entire data and to propose a model of 
tertiary structure for the nrdS intron of Bacteriophage T4. 
In the end, a brief summary of the work and bibliography are docu-
mented. 
C'HAPXER Is Review of literai^re 
1 
Genes are found to be interrupted by non-coding stretches, the so called 
introns in almost all classes of organisms. Therefore, processing of the 
genes has to be carried out in order to express them smoothly. Interrupted 
genes represent a minor proportion of the genome of the lower eukaryotes, 
but the vast majority of genes in higher eukaryotic genomes are interrupted. 
The primary transcript has the same organization as the gene, and is some-
times called the pre-mRNA. Removal of these intervening sequences from 
pre-mRNA leaves a typical messenger RNA by the process of the so called 
RNA splicing. In eukaryotes it occurs within the nucleus. The process of 
splicing together with other modifications is called post-transcriptional modi-
fication. The processed mRNA is now ready for the translation process 
(Sharp, 1987; Cech, 1988). 
In general, prokaryotic genes do not have introns because its genome 
tend to be smaller and replicate faster than eukaryotic genomes. There-
fore, It is thought that introns and other non-coding DNA sequences have 
been kept out of prokaryotes. But an extreme exception is the occurrence 
of three introns in bacteriophage T4 (Belfort, 1990). 
DISCOVERY OF INTRONS 
Introns were discovered in 1977 and heralded a new era in the study 
of molecular biology of eukaryotic gene expression (Berezney and Coffey, 
1977). The complexity of gene organization, the combinatorial possibilities 
of assembling different coding exons from an RNA precursor, and the nov-
elty of the RNA splicing process clearly indicated that eukaryotic molecular 
biology would be fascinatingly different from that of prokaryotic system 
(Green, 1986; Padgett et al, 1986). But recent report by Morrisy and Tollervey 
(1995) highlights the striking similarity between prokaryotic (Doolittle,1995) 
and eukaryotic systems. Their evidence for a common origin of ribosomal 
RNA processing in eukarya, archaea and bacteria can be shown by the fact 
that the pre-rRNA processing has now been found in archaeon, Solfolobus 
acidocaldahus (Poter et al, 1995). 
Group I introns have been discovered in mitochondrial precursor RNA 
genes of fungi, plants, chioroplasts and bacteriophages (Cech, 1990), and 
recently in tRNA gene of eubacteria (Reinhold-Hurek and Shub, 1992). 
Based on all known group I intron sequences , comparative folding analy-
ses and computer search for structure with the minimum free energy of fold-
ing were performed and a generic secondary structure was derived (Wittop-
Koning and Schumperii, 1994). 
The conservation of short sequences among group I fungal 
mitochondrial introns was first noted in 1982 by Burke and Rajbhandary, 
Michel and coworkers as well as Davies and his associates independently. 
The latter two groups further showed that these introns, although quite dif-
ferent in primary sequences, could all be folded into a secondary structure 
that had a common core region. Extra nucleotides , often including long 
open reading frames, form stem-loop structures that are peripheral to the 
core. The same core structure is shared by nuclear rRNA introns in Tetrahymena, 
Physarum, and Pneumocystic chloroplast tRNA introns in higher plants, 
chloroplast mRNA and rRNA introns in Chlamydomonas, and mRNA introns in 
bacteriophages T4 and SP01. Most of the conserved nucleotides exist 
within the four short sequences P,Q,R and S. These sequences al-
ways occur in the same order along the intron (5'-P-Q-R-S-3') but the dis-
tance between adjacent sequence elements can vary from approximately 
twenty nucleotides to many hundreds of nucleotides. The only other 
nucleotides known to be highly conserved among group I introns are the U 
preceding the 5' splice site and the G to which It pairs a G.C base pair in P3 
and G preceding the 3' splice site (Cech, 1988). 
TYPES OF INTRONS 
Introns have been categorized into four major groups on the basis of 
their conserved nucleotide sequences and RNA structures located within 
and adjacent to intron (Cech, 1988). These are group I, group II , nuclear 
mRNA and nuclear tRNA (Fig. 1). 
The group I and group II introns are particularly interesting from the 
view point of RNA structure because they fold to form active sites to accom-
plish their own splicing (Kruger et al, 1982; Peebles et al,1986 ;Van der 
Veen et al, 1986; Kim and Cech, 1987; Michel and Westhof, 1990). 
Group I introns are further classified on the basis of distinctive struc-
ture and sequence features into four sub-groups, designated lA, IB, IC and 
ID (Michel and Westhof, 1990). Group lA introns for example, contain two 
extra pairings, P7.1/P7.1a or P7.1/P7.2 between P3 and P7, whereas many 
group IB and IC introns have a large extension of P5, termed PSabc (Fig. 
2b). Individual introns may contain additional sequences, including open 
reading frames (ORF) in positions that do not disrupt the conserved core 
structure (Saldanha et al, 1993). 
Group II introns are present in fungal, plant mitochondria and plant 
chloroplasts as well as in prokaryotic genomes (Michel et al, 1989a; Ferat 
and Michel, 1993). These are also self-splicing introns (Peebles etal, 1986; 
Schmelzer and Schweven, 1986; Van der Veen et al, 1986). But splicing 
mechanism is slightly different from that of group I introns. The self-splicing 
of group 11 introns occurs in the absence of a nucleotide cofactor since 
2'hydroxyl group at the branch site participates in the first trans-esterification 
reaction (Peebles et al, 1986; Van der Veen et al, 1986). 
The splicing process of nuclear mRNAs (Type III introns) is closely 
related to that of RNA-catalyzed self-splicing reaction (Sharp, 1985; Cech, 
1986). Any catalytic RNA involved in the splicing of mRNA precursors could 
not be part of the precursor RNA, since mutational analysis has shown that 
the only intron sequences essential for splicing are the limited consensus 
sequences near the 5'and 3'splice sites (Wieringa et al, 1983). The obvi-
ous candidates for specifying this hypothetical catalytic RNA structure are 
the highly evolutionary conserved small nuclear RNAs (Lernarand Steitz, 
1981; Maniatis and Reed, 1987). These RNAs are present in the nucleus as 
ribonucleoprotein particles (Lerner and Steitz, 1981; Busch et al, 1982). 
Type IV introns i.e. nuclear tRNAs possess the endonuclease activity and 
require ATP as energy source (Lambowitz, 1989). 
SECONDARY STRUCTURE OF RNA 
Structure - Functional Relationship: Sequence and secondary structure 
comparisons among the group I introns have uncovered highly conserved 
features, which are likely to guide RNA folding and thus be important in 
splicing (Davies et al, 1982; Michel et al, 1982; Cech et al, 1983). 
Moreover, the cis - dominant intron mutations that disrupt splicing of yeast 
mitochondrial RNA as well as second-site revertants of these mutations have 
implicated intron elements that are functionally important (Anziano et al, 
1982; De La salle et al, 1982, Weiss-Brummer et al, 1983; Holl et al, 1985). 
Furthermore, a spontaneous splicing defective mutation in Tetrahymena 
large rRNA gene has been isolated in the heterologous Escherichia coli 
(Waring et al, 1986). Other approaches have relied on site-directed 
mutagenesis (Burke et al, 1986; Waring et al, 1986), or use of artificial 
substrates in vitro splicing reactions (Sullivan and Cech, 1985; Garriga et 
al,1986) to ascribe functional relevance to specific residues within ribozymes 
of Tetrahymena and Neurospora. 
SECONDARY STRUCTURE OF T4 INTRONS AND THEIR RELATIONSHIP 
TO EUKARYOTIC INTRONS 
The core structure of group I introns is based on both local and long 
range complementary base-pairing region (Davies et al, 1982 Cech et al, 
1983; Michel and Dujon, 1983). This model of core structure of group I introns 
holds good in all members of this group (Waring and Davies, 1984; Michel 
and Gumming, 1985). The three T4 introns bear a remarkable resemblance, 
both in secondary structure and in conserved sequence elements ,to the 
group I introns of eukaryotes. They belong to a subset, Group lA, that is 
characterized by systematic variations in the highly conserved sequences 
P,Q,R and S and by one ( or, rarely two) extra stem loop structures between 
the P7 and P3 pairing (Michel and Dujon, 1983; Waring and Davies, 1984). 
Identification of P and Q sequences ( parts of which pair to form the P4 
stem) as well as the R and S sequences ( parts of which pair to form the P7 
helix) is critical to generate the correct core structure (Fig. 2a). Although P 
and Q sequences deviate from the consensus, compensatory changes al-
low the two sequences to pair in the expected way for each of the T4 introns 
(Shub et al, 1988). Now the structure for the td intron predicts P and Q 
sequences that are different (Shub et al, 1988) from those originally as-
signed by Chu et al (1986) but agree with their recent reassignments (Chu 
et al, 1987). The T4 introns conform to the group I intron core structure not 
only with respect to the central P3, P4, P7 pairing , but also with respect to 
the intron-exon alignment (P1 pairing). The internal guide squence (IGS), 
near the 5' end of the intron, has been proposed to precisely align the 5' 
splice site by pairing with the upstream exon. The terminal uridine of exonl 
always pairs with a guanosine in the IGS. These requirements are exactly 
met in all the three intron models, it also shows the striking similarities 
among the T4 introns. First, each contains two stem-loop structures {P7.1 
and P7.2) between the R sequence of P7 and P3 pairing consistent with 
their status as group lA introns. Second, the three introns have in common 
two additional stem-loop structures after P9. Third, there is extensive con-
servation of sequences at equivalent positions of the core structure, ex-
tending well beyond the sequences that are conserved in all group I introns. 
Among these, conserved regions are the P7.2 stem-loop and its unpaired 
flanking regions, the P9 and P9.2 stem loop structures and the unpaired 
residues extending to the 3'end of the introns. While this homology clearly 
reflects the common ancestry of the T4 introns, it is interesting that these 
sequences have diverged less than other structural elements (e.g. P3 and 
P4 ) that are central to the core structure of group I introns. This implies a 
common function for the conserved T4 sequences. The only major struc-
tural differences among the T4 introns are the positions of the intron ORF 
and the lack of the P2 stem in the nrdD (sunY) intron. P2 is also an optional 
element in eukaryotic group I introns (Michel and Dujon, 1983; Waring and 
Davies, 1984) 
A significant degree of sequence conservation also exists beyond the 
intron boundaries extending 10-12 nucleotides to each side of the splice 
junction. This may reflect a target site for intron insertion and / or interac-
tions with the core structure of the intron. Although many group I introns 
contain ORFs but they are looped out from the core structure. The position 
of the ORFs within the T4 introns (P6 and P9.1) is not typical. In addition, 
unlike many introns of this type , the T4 intron ORF overlaps structural 
elements and is thought to be involved in splicing (Hall et al, 1987). Both 
the td and nrdB intron ORFs extend past the P6 stem, ending within the 
highly conserved R sequence whereas the sunY intron has an ORF that 
overlaps P9.2, the last structural element of the intron. These arrangements 
are not without precedent. An intron in the large rRNA gene of 
Chlamydmonas reinhardii chloroplasts bears a remarkable structural re-
semblance to the td and nrdB introns sharing with them all of the unusual 
features (Rochaix et al, 1985). Similarly the placement of the ORF within 
the nrdD intron resembles that in the three fungal mitochondrial introns 
(Waring and Davies, 1984 ; Michel and Gumming, 1985). Although the se-
quences of the T4 introns (outside of the conserved group I elements) are 
not similar to their eukaryotic counterparts, the striking structural similarity 
between the prokaryotic and eukaryotic introns suggest a common evolu-
tionary origin. These structural features are likely to reflect common func-
tions carried out by RNA molecules from these widely divergent sources. 
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SELF SPLICING 
In the genes of eukaryotes, coding sequences are often interrupted 
by stretches of noncoding DNA. The primary transcripts of such genes must 
undergo cleavage-ligation reactions. Two different mechanisms have been 
described by which catalytic RNAs can remove their own introns in vitro, 
and are classified as group I and group II self splicing introns. These introns 
are characterized by short conserved sequences as well as their potential 
to fold into complex secondary and tertiary structures that are conserved 
despite a high degree of primary sequence divergence (Jacquier, 1990). A 
third class of organelle introns the so called group III introns do not show 
self-splicing activity in vitro (Christopher and Hallick, 1989). 
SELF SPLICING OF GROUP I INTRONS 
Cech and colleagues (1981) found that a ribosomal precursor RNA of 
Tetrahymena could remove its own 413 nts long intron in the absence of 
proteins in vitro. This reaction proceeds by two consecutive trans-
esterification reactions and requires a divalent cation ( Mg*^ or Mn*^ ) as 
well as guanosine ( or a guanosine phosphate) which becomes covalently 
linked to the 5' end of the intron during the reaction. The 3'end of the 5' 
exon forms a hybrid with an internal guide sequence (IGS) in the 5' end of 
the Intron. The trans-esterification reaction is initiated by the external 
guanosine, which is held in a guanosine binding site of the intron hydrogen 
bridges. The 3'-0H of this guanosine attacks the phosphorus atom at the 5' 
splice site and forms 3',5'-phosphodiester bond to the first nucleotide of the 
intron. Mg*^ is thought to stabilize the reaction intermediate by directly in-
teracting with the 3' oxygen of the attacked phosphodiester bond ( Piccirilli 
et al, 1993). Altered group I intron have been generated whose cleavage 
depends on the four fold larger Ca*^ ions (Lehman and Joyce, 1993). In the 
second trans-esterification step, the free 3' hydroxyl group at the 3' splice 
site, brings about the ligation of the exons and removal of the linear intron 
(LIVS), the extra guanosine remaining at Its 5' end. During this reaction, 
the conserved 3' guanosine from the intron remains bound at the G-bind-
ing site. Subsequently, the intron itself undergoes a self-catalyzed trans-
esterification reaction. The conserved terminal 3' guanosine residue still 
bound in the G-binding site attacks a phosphorus atom near the end of the 
molecule resulting in intron cyclization (CIVS) and removal of short 5' 
oligonucleotide. 
Group I self splicing is very sensitive to mutation in core of this struc-
ture but many of the peripheral stem-loop structures can be deleted without 
loss of splicing function in vivo. These structures may , however , play a 
role in stabilizing the intron or providing binding sites for proteins which 
facilitate or regulate self splicing in vivo. Introns themselves may infact 
encode a protein, involved in their own structural stabilization (Lambowitz, 
1989). 
SELF-SPLICING REACTION PATHWAY 
Splicing: The self splicing of group I Introns proceeds by two consecutive 
trans-esterification reactions. The first of these is initiated by guanosine or 
one of its 5'-phosphorylated forms (GMP, GDP, or GTP ) which attacks the 
phosphorus atom at the 5' splice site and forms a 3',5'-phosphodiester bond 
to the first nucleotide of the intron. The 5' exon, now terminating in a free 3' 
hydroxyl group, then attacks the phosphorus atom at the 3' splice site (Fig. 
3). This results in ligation of the exons and excision of the intron. This splic-
ing pathway was first worked out for the Tetrahymena thermophila nuclear 
pre-rRNA (Zaug et al, 1983; Cech, 1987; Been et al, 1988). It was subse-
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quently found applicable to self splicing of precursor RNA containing 
group I introns from diverse sources, including a Neurospora crassa 
mitochondrial pre-mRNA (Garriga and Lambowitz, 1984), several 
Saccharomyces cerivisiae mitochondrial pre-mRNA and pre-rRNA (Van der 
Horst and Tabak, 1985; Gampel and Tzagoloff, 1987; Partono and Lewin, 
1988), several bacteriophage T4 and SP01 pre-mRNA (Chu et al, 1986; 
Gott et al, 1986; Goodrich-Blair et al, 1989) and nuclear pre-mRNA from 
Physarum polycephalum and Pneumocystis carina (Sogin and Edman, 1989). 
Guanosine addition also occurs to the 5' end of the N. crassa 
mitochondrial rRNA group I intron during splicing in vivo (Garriga and 
Lambowitz, 1983). This RNA does not undergo detectible self splicing in 
vitro, but nevertheless shares this mechanistic hallmark of group I RNA 
splicing. The evidence for the reaction pathway shown in N. crassa includes 
characterization of the products and intermediates at the level of individual 
nucleotides and, in the case of Tetrahymena pre-rRNA, at individual phos-
phates. The phosphate to which G is added is derived from the UpA at the 
5' splice site of the pre-rRNA (Zaug et al, 1983) whereas the phosphate at 
the ligation junction is derived from the GpU at the 3' splice site (Price et al, 
1987a). The proposed intermediate has been characterized in vitro (Inoue 
et al, 1986) and observed in RNA produced in vivo (Kister and Eckert, 
1987). Another prediction of the trans-esterification model that is the re-
versibility of the reaction in the absence of exogenous guanosine and the 
inversion of configuration around phosphorus have been verified. The 
nucleotidyl transfer reaction bears similarity to reactions catalyzed by DNA 
and RNA polymerases, with the difference that the nucleophile 3'-0H at-
tacks a phosphorus atom involved in a phosphodiester linkage during splic-
ing and one involved in a phosphoanhydride linkage during nucleic acid 
synthesis. These reactions are also similar to those catalyzed by DNA 
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topoisomerases and recombination enzymes. However, the nucleophile is 
a 3'-OH in splicing rather than an amino acid side chain (e.g. tyrosine 
hydroxyl group in the case of E.coli DNA gyrase; Tse et al, 1980). Two of 
the other three classes of RNA splicing also occur by trans-esterification 
with conservation of the number of 0-P bonds throughout the reaction. These 
differ from group I RNA splicing in that the nucleophile is a 2'-0H instead of 
a3'-0H. 
Hydrolysis of Splice Site: Both the 5' and 3' splice site phosphodiester 
bonds of the Tetrahymena pre-rRNA are usually susceptible to hydrolysis 
(Zaug et al, 1984, 1985; Inoue et al, 1986). Thus in the absence of 
guanosine, the pre-rRNA is slowly cleaved at these sites. The cleavage 
products have 5'-phosphate and 3'-hydroxyl termini, consistent with the 
mechanism of splicing but opposite to the end-groups left by random alka-
line hydrolysis of RNA. Site-specific hydrolysis is thought to reflect the ability 
of the folded RNA structure to activate the splice-site phosphates or the 
incoming nucleophile, using the same catalytic mechanism which is respon-
sible for self splicing. The rate of hydrolysis of the phosphodiester bond 
following the 3'-terminal G of the intron is greatly accelarated; the second 
order rate constant is about 10 orders of magnitude higher than that calcu-
lated for hydrolysis of an average phosphodiester bond in RNA giving the 
same 5'-phosphate / 3'-hydroxyl end - groups (Zaug and Cech, 1986a, 
1986b). Specific hydrolyses at the 5' splice site and at the cyclization site 
are also enhanced, although not as much as at the 3' splice site (Inoue et 
al, 1986; Tanner and Cech, 1987). Thus , while all phosphodiester bonds 
are energetically equal as far as their RNA synthesis is concerned, they 
can have vastly unequal stability in the context of a particular folded RNA 
structure ( Cech, 1987). 
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Intron Cyclization and Trans-esterification Reaction: The trans-esterification 
mechanism was discovered by Blum et al (1991). The splicing of group I 
intron proceeds by two consecutive transesterification reactions . The first 
of these involves guanosine or one of its 5'-phosphorylated form (GMP, 
GDP or GTP) which attacks the phosphorus atom at the splice site and 
forms a 3',5'- phosphodiester bond to the first nucleotide of the intron (Fig. 
3). The 5'exon, now terminating in a free 3'-hydroxyl groups , then attacks 
the phosphorus atom at the 3'-splice site which results in ligation of the 
exon and removal of the intron (Herschlag and Cech, 1990a). 
The evidence for this reaction pathway includes characterization of 
products and intermediates at the level of individual phosphate. The phos-
phate to which G is added is derived from the UpA at the 5' splice site of the 
pre-rRNA (Cech, 1987). The phosphate at the ligation junction is derived 
from the GpU at the 3' splice site ( Price et al, 1987b). The divalent cation 
( Mg** or Mn*^) are also required for efficient splicing (Menger et al, 1996). 
The Tetrahymena intron undergoes an intra molecular cyclization reaction 
after the removal from pre-rRNA (Garriga and Lambowitz, 1983). This reac-
tion is also self catalyzed and again occurs by transesterification, with the 
3'-terminal G-OH of the RNA attacking of phosphorus atom located near 
the 5' end of molecule ( Zaug et al, 1983). A 3' terminal guanosine is con-
served among group I introns and cyclization is common but not universal 
among this group. 
A variety of self catalyzed, splicing related reactions including 
cyclization of excised IVS RNA, oligomerization of IVS RNA and 
intramolecular exon ligation were found to take place by concomitant cleav-
age and rejoining of RNA (Inoue et al, 1986; Tabak et al, 1987). These were 
readily explained by trans-esterification model. The postulated splicing in-
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termedjate was subsequently detected, purified and found to undergo sec-
ond step of splicing on incubation with an oligonucleotides analog of 5' 
exon ( Zaug and Cech, 1985). The splice junction phosphate was derived 
from the 3' splice site as predicted. Finally, a transesterification reaction 
and the cyclization of excised IVS RNA have been shown to be reversible 
( Sullivan and Cech, 1985). 
SPLICE SITE 
There is a simple rule that determines the 5' splice site of all group I 
introns that is the last nucleotides of the 5' exon are involved in base pair-
ing ( called P I ) , with a complementary sequence located within the intron, 
5' to its active core. In almost all cases (including nrdD) the exon ends with 
a U, which was paired to a G in the intron. This rule which was originally 
proposed as the basis of sequence comparisons ( Davies et al, 1982; Michel 
et al, 1982) has subsequently been experimentally confirmed (Been and 
Cech, 1985, 1986; Waring et al, 1986). The PI pairing may be sufficient to 
specify the 5' cleavage site because point mutations in the exon destabilizing 
PI can activate cryptic 5' splice sites that mimic the original pairing (Chandry 
and Belfort, 1987; Price et al, 1987b). The specificity at the 3' splice site is 
not well understood. All group I introns end with a G and changing that 
nucleotide to U or C in the intron of the large rRNA of Tetrahymena 
thermophila allows only residual splicing ( Price and Cech, 1988). Also the 
two nucleotides immediately preceding the 3- terminal G of the Tetrahymena 
intron have been shown to contribute significantly to binding of the 3' splice 
junction by the catalytic core ( Tanner and Cech, 1987). Indeed mutation in 
the penultimate residues of the intron results in slowing the rate of splicing, 
without changing its specificity (Price and Cech, 1988) . Moreover, Davies 
et al (1982) noted that 5' to the intron residues that pair with the 5' exon to 
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form helix P1, there are usually several additional residues that can pair 
(P10) with the first several residues of the 3' exon. Most group I introns 
would thus include an internal guide sequence which, by pairing with both 
5' and 3'exon residues ( P1 and P10) would align the two exons for the 
ligation step (Shub et al, 1988; Doudona and Szostak, 1989a, 1989b; Xu 
and Shub, 1989). 
T4 INTRONS 
The bacteriophage T4 genome contains three introns (Fig. 4), at least 
two of which are in genes coding for enzymes involved in nucleotide 
biosynthesis. The first T4 intron was discovered in 1984 in the thymidylate 
synthase (td) gene (Chu et al, 1984). It raised the question of generality of 
introns and RNA splicing in prokaryotes. While introns have been reported 
to exist in archae-bacterial tRNA (Kaine et al, 1983; Daniel et al, 1985) and 
rRNA (Kjems and Garrett, 1985), the phylogenetic status of these 
prokaryotes is unusual. Archaebacteria have more characteristics in com-
mon with eukaryotes than do eubacteria and may form a third primary king-
dom ( Foxet al, 1980). This 1016 bp intervening sequence in fd gene of T4 
splits into two exons of 183 amino acids (exon I ) and 103 amino acids 
(exon II). Subsequently, an intron of 598 bp was found on the nrdB gene 
encoding the small subunit of ribonucleotide reductase ( Sjoberg et al, 1986) 
and an intron of 1030 was found in nrdD (previously abbreviated as sunY) 
gene encoding an anaerobic ribonucleotide reductase (Gott et al, 1986). 
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SPLICING OF T4 INTRONS 
The T4 introns have the ability to self-splice in vitro (Chu et al, 1986; 
Gott et al, 1986). Autocatalysis is enabled by folding of the intron into char-
acteristic secondary structure that facilitates a series of trans-esterification 
reactions necessary for intron excision and exon ligation (Belfort, 1990). 
This critical ribozyme secondary structure comprises of ten RNA pairing 
regions ( PI - P10) which along with conserved primary sequence elements 
P,Q,R,S identify the T4 intervening sequences as group I intron ( Cech, 
1988; Shub et al, 1988; Saldanha et al, 1993). The T4 td intron contains 
four long range base paired regions in P3, P6, P7 and P10 . The remaining 
base paired regions are stem-loop structure including P7.1 and P7.2 which 
coupled with specific variants in the P,Q,R,S sequence elements further 
subclassify the T4 introns as group lA (Cech, 1988; Belfort, 1990). 
The secondary structure model for group I intron was initially postu-
lated on the basis of phylogenetic comparisons of intron sequences from 
various organisms which predicted a common secondary structure ( Davies 
et al, 1982; Michel et al, 1982; Waring and Davies, 1984). Since then, mu-
tatiorral analysis of autocatalytic group I intron in Tetrahymena, T4 and yeast 
mitochondria has identified many splicing defective cis-acting intron muta-
tions that would destabilize predicted RNA pairing regions , thus generally 
supporting the model. In T4, for example, the sequence changes for 31 
splicing defective td intron mutants (19 phage mutants, 12 mutations from a 
cloned td gene) have been determined and the vast majority disrupt pro-
posed intron RNA helices ( Chandry and Belfort, 1987; Hall et al, 1987; 
Ehrenman et al, 1989; Brown et al, 1993). 
Single base changes in predicted RNA pairing regions which disrupt 
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splicing, provides proof that a nucleotide is essential for the splicing reac-
tion. Genetic verification that a base pairs (and thus a pairing region ) ex-
ists, can be demonstrated by the isolation of a pseudorevertant that har-
bours a compensatory mutation at the nucleotide predicted to base pair 
with the original mutant nucleotide. The double mutant would be predicted 
to regenerate a Watson-Crick base pair in an essential RNA helix, thus 
permitting intron RNA to fold, resulting in the restoration of some degree of 
autocatalytic splicing. Such experiments have been carried out using site-
specific mutagenesis to verify the existence of group I intron RNA pairing 
region in Tetrahymena and yeast mitochondria (Weiss-Brummer et al, 1983; 
Hon et al, 1985; Burke, 1988; Flor et al, 1989; Williamson et al, 1989; Cou-
ture et al, 1990). For the T4 introns, however, only the P6 pairing region of 
the td intron has been proven by isolation of such second site suppressor 
mutations (Ehrenman et al, 1989). 
PROBABLE ROLE OF INTRONS IN T4 PHAGE 
It is generally true that prokaryotic genes do not have introns. Because 
prokaryotic genomes tend to be smaller and replicate faster than eukaryotic 
genomes, it is thought that introns and other non-essential DNA sequences 
have been kept out of prokaryotes by selective pressure to streamline the 
genome (Hickey et al, 1989). An extreme exception is the occurrence of 
three group I introns in the coliphage T4 (Belfort, 1990). Phage T4 has a 
166 Kb DNA genome, which otherwise appears to be highly streamlined, for 
example, promoters and even translational initiation regions are often found 
to lie nested within the coding sequence of upstream genes. The presence 
of these introns in the space-efficient T4 genome suggest that there is 
some selective pressure keeping them there. 
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The introns occur in the genes encoding the phage dTMP synthase 
(td), the small subunit of the phage nucleotide reductase (nrdB), and an 
anaerobic ribonucleotide reductase (nrdD). It is curious that the two pro-
teins of a known functions catalyse the steps in the same pathway i.e. de 
novo dNTP synthesis from rNTP pool. Moreover, they lie at the only two 
steps that consume reducing equivalents ( ultimately NADPH) from the re-
serves of the host cell. Group I splicing itself relies on an exogenous 
ribonucleotide and may be inhibited by guanosine analog. These introns 
are involved in a feedback regulatory loop that controls the level of dNTP 
synthesis in the infected cell and, therefore, confer a selective advantage 
upon intron- containing phage (Gott et al, 1986; Goodrich-Blair et al, 1990). 
A different hypothesis proposes that the introns are mobile genetic 
elements. This was suggested by the inconsistent occurrence of the introns 
in the closely related phages T2 and T6 (T2 has no intron, and T6 has only 
td intron) (Pedersen-Lane & Belfort, 1987; Quirk et al, 1989a). This hypoth-
esis has been substantiated by recent direct experimental evidence dem-
onstrating that the Wand nrdD introns are indeed actively mobile (Quirk et 
al, 1989b) and both introns encode DNA endonucleases highly specific for 
intron-less td (Bell-Pedersen et al, 1989, 1990; Chu et al, 1990) or nrdD 
genes (Bell-Pedersen, 1990). The resulting double-stranded DNA breaks 
appear to initiate an efficient unidirectional gene conversion event, result-
ing in the conversion of intron-less to intron-plus gene in a mixed infection. 
This high-frequency conversion to intron plus genes might be expected to 
easily maintain the introns in the phage population, even in the face of 
other selective pressure to remove them. Group I introns mobility appears 
to be general phenomenon (Dujon, 1989; Perlman and Butow, 1989; 
Scazzacchio, 1989). Although high frequency intron mobility may account 
for the presence of the td and nrdD introns in T4, it fails to explain the 
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presence of the immobile nrdB intron. 
SPLICING OF INTRONS IN PROKARYOTES 
Splicing of introns in prokaryotes are carried out by two trans-
esterification reactions initiated by nucleophilic attack of guanosine at 5' 
splice site. This process depends on conserved secondary and tertiary struc-
tures that direct folding of the intron such that the 5' and 3' splice sites are 
juxtaposed to the guanosine-binding site within the introns' catalytic core 
(Cech, 1990; Michel and Westhof, 1990; Cech et al, 1992; Saldanha et al, 
1993). The Tetrahymena intron splices 50-fold more efficiently in vivo than 
in vitro ( Brehm and Cech, 1983) suggesting for the involvement of acces-
sory factors during in vivo splicing. In addition, two groups of accessory 
proteins that regulate splicing of fungal mitochondrial introns have been 
defined by genetic criteria (Burke, 1988; Lambowitz and Perlman, 1990). 
First type is the introns encoded proteins called maturase that facilitate 
splicing of their cognate introns (Anziano et al, 1982; De La Salle et al, 
1982; Lazowska et al, 1989). Second type belongs to the nuclear-encoded 
splicing proteins ( Burke, 1988; Lambowitz and Perlman, 1990). The best 
characterized of these proteins are found in Neurospora where a mutation 
in the cyf18 gene blocks splicing of a number of group I introns in vivo, 
including the C0B1 intron, which can self splice in vitro (Garriga and 
Lambowitz, 1984, 1986). CYT-18 protein which corresponds to mitochondrial 
tyrosyl tRNA synthetase ( Akins and Lambowitz, 1987) binds specifically to 
the mitochondrial large subunit rRNA (LSD) intron with high affinity (Guo 
and Lambowitz, 1992). CYT-18 can also promote splicing of mutant T4 td 
introns both in vivo and in vitro (Mohr et al, 1992) suggesting that the pro-
tein acts by stabilizing the correct tertiary structure of the introns (Guo and 
Lambowitz, 1992). 
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A role for protein factors in modulating splicing of the T4 introns in 
vivo is suggested by several observations. First, both the nrdB and nrdD 
introns require elevated monovalent ion concentrations to splice efficiently 
in vitro (Hicke et al, 1989). Second, utilization of a cryptic 5' splice site by 
the td intron is reduced in vivo compared with in vitro (Chandry, 1991). Third, 
the td intron splices more efficiently in vitro at elevated temperature (Chu et 
al, 1987). Fourth, analysis of a fd trans-splicing reaction revealed that the 
in vitro reaction occurs efficiently only at high temperature ( 55° C), whereas 
the td intron is capable of trans-splicing in vivo at physiological tempera-
ture (Galloway-Salvo et al, 1990). Several findings suggested that facilitatory 
factors may be present within the cell, prompting attempts to purify these 
putative factors. Using stimulation of trans-splicing as an initial in vitro as-
say, Coetzee et al (1994) identified an activity that facilitated both trans-
and cis-spllcing of the td intron. This activity, vy^ich also promoted splicing 
of the nrdB and sunY (nrdD) introns, comprises multiple proteins that have 
different activities for splicing enhancement. Several of these are ribosomal 
proteins, with ribosomal protein SI 2 being the most active (Coetzee et al, 
1994). Functional analysis suggests that these proteins are mechanistically 
distinct from those that specifically enhance group I splicing and, rather, 
serve to facilitate formation of the active conformation of the intron by act-
ing as RNA chaperones (Coetzee et al, 1994). 
CHARACTERISTICS OF T4 td INTRON 
It has been reported that the td gene encoding T4 phage thymidylate 
synthase is interrupted by a 1017 base pair intron between the triplets cod-
ing for glycine 183 (GGT)and leucine 184 (CTA) (Chu et al, 1984). Expres-
sion of td gene was shown subsequently to involve post transcriptional 
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processing of the primary transcript both in vivo ( Belfort et al, 1985) and in 
vitro systems (Chu et al, 1985). The nucleotide sequence of the entire td 
intron has now been determined using overlapping deletions of the td gene 
in Ml 3 recombinant clones. As in the case of most class I introns, which 
include the self splicing intron of the nuclear large rRNA in Tetrahymena 
thermophila and the introns in yeast and fungal mitochondrial genes (Cech, 
1983) the td intron is preceded by a U and ends in a G. In addition, the 
nucleotide sequences at the td splice sites of exonl-intron (GGUUAA) and 
intron-exonll (AUGCUG) show a fair degree of homology to their eukaryotic 
counterparts. Furthermore, at least four conserved nucleotide sequences 
(boxes P,Q,9L,and 2) found in class I introns (Burke and Rajbhandary, 1982; 
Michel et al, 1982; Waring and Davies, 1984) were discernable in the td 
intron and exhibited some degree of homology. Moreover, the box 9L and 2 
sequences are highly conserved in the td intron especially the internal 5 
nucleotide stretch in each box. These pentanucleotide sequences have been 
shown to form a stable base-paired region in the Tetrahymena rRNA that is 
believed to facilitate the proper intron excision and exon splicing from pre-
cursor RNA (Burke et al, 1986, 1987). 
SPLICING OF foriNTRON 
The splicing in td intron involves covalent addition of a guanosine 
residue to its 5' end by an apparently energy-independent trans-esterification 
reaction (Hall et al, 1987). One end product of the reaction is a circular 
intron RNA that is likely to be covalently closed by a 3'-5' linkage, with 
concomitant loss of the two 5' residues of the intervening sequence (Hall et 
al, 1987). Loss of nucleotides from the 5' intron terminus suggests that this 
cyclization event is mechanistically similar to that of the Tetrahymena rRNA 
intron (Zaug et al, 1983) and the yeast mitochondrial rRNA intervening se-
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quence (Tabak et al, 1984). In these cases, 15 and 4 nucleotides, respec-
tively are removed upon formation of the 3'-5' linkage between the 3'termi-
nal guanosine and the selected Internal intron residue. In addition to 
cyclizatlon site between the 16 and 16 nucleotide of Tetrahymena intron, 
there is minor site between the residues 19 and 20 (Zaug et al, 1984). 
Infact the 3' guanosine adds to an internal bond, 3' to a uridine residue. 
This observation suggests that the conserved uridine may be a major de-
terminant in cyclization site recognition, much as the conserved uridine at 
the 3' end of the upstream exon is important in targeting the 5'splice site. 
Davies and co-workers (1982) proposed pairings between internal guide 
sequences and exon sequences around the splice sites as major determi-
nants in targeting splice sites. Furthermore, since di- and tri-nucleotides 
similar to the sequences preceding the Tetrahymena rRNA 5' splice site 
(UCU) and the major and minor cyclization sites (UUU and CCU) are capa-
ble of reopening the circle, Sullivan and Cech (1985) proposed a 
trinucleotide binding site within the intron that guides the choice of the ap-
propriate cleavage-ligation site. Consistent with such a model is the simi-
larity of the sequences upstream of the yeast mitochondrial rRNA 5' splice 
site (GAU) and cyclization site (AAU). In case of the td gene there are only 
2 nucleotides, (i.e. GU) preceding the cyclization site, the guanosine being 
the non-coded adduct. These residues are, however, identical to the GU 
upstream of 5'splice site. It would appear, therefore, that in td RNA splicing 
a dinucleotide may be sufficient to impart specificity to splice site selection. 
Regardless of evolutionary relationship, the parallels between td intron and 
other group I intervening sequences make the td gene an attractive model 
system for studying this type of reaction, using facile prokaryotic genetic 
techniques (Ehrenman et al, 1986). 
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THE nrdB GENE OF T4 PHAGE 
Bacteriophage T4-encodeci ribonucleotide reductase is required in the 
assembly of the dNTP synthetase complex (Chiu et al, 1982; Moen et al, 
1988) and appears to be the last factor and the keystone in the assembly 
of the complex (Hiifinger and Ping, 1994). The alpha and beta chains of this 
alpha 2 beta 2 enzymes are encoded by the T4 nrdA gene and intron con-
taining nrdB gene, respectively (Tseng et al, 1988, 1990). The synthesis of 
the beta 2 subunit is initiated after the synthesis of alpha 2 protein begins 
(Tomich et al, 1974; Chiu et al, 1976, 1982). 
The nrdB intron of bacteriophage T4 contains 598 base pairs. This 
intron is closely related to other group I introns of T4 and eukaryotes (Sjoberg 
et al, 1986). The secondary structure of nrdB intron like td and other 
group I introns is comprised of various stem-loop structures. Besides these 
stem-loop structures, other pairing regions are also found to facilitate the 
secondary structure formation of intron (Davies et al, 1982; Cech et al, 1983; 
Michel and Dujon, 1983). The nrdB intron belongs to a sub-group, lA, that 
is characterized by systematic variations in the highly conserved sequences 
P, Q, R, and S (Michel and Dujon, 1983; Waring and Davies, 1984). It 
contains an extra domain (stem-loop P7.1 and P7.2) between the 3' end of 
P7 [5'] and 5' end P3 [3'] (Waring and Davies, 1984). The P6 pairing of the 
nrdB intron consists of 3 base pairs, two of which are G-C pairs and one is 
a G-U pair. Sequences peripheral to P6 are not required for td intron splic-
ing. Infact all the splicing-defective mutants in the td intron clustered out-
side the ORF (Belfort et al, 1987; Ehrenman et al, 1989). Compensatory 
mutants in td exhibit only partial function in vivo and are inactive under 
stringent in vitro conditions, demonstrating that although the P6 pairing is 
necessary for splicing activity, there is a sequence specificity for P6 [5'] 
and / or P6 [3']. These functional constraints appear to be reflected in the 
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high degree of conservation of P6 among all two 3' residues of element Q 
and P6 (3'] forming the two 5' residues of R (Q and R being two of the four 
conserved group I sequence elements (Lai and Hall, 1997). 
ETHYLMETHANE SULPHONATE (EMS) AS A MUTAGEN 
EMS is an alkylating agent which was discovered by Loveless to in-
duce mutations in Bacteriophage T2 (Loveless, 1958). The induced muta-
tion may be delayed by several genarations (Green and Krieg, 1961). This 
mutagen generally reacts with three (i.e. A, G, and C) of the four bases of 
DNA (Brookes and Lawley, 1960; Pal, 1962). EMS induces the GC to AT at 
a much higher rate than the AT to GC transition. The replacement of purine-
pyrimidine pair by a pyrimidine-purine pair may also be induced to some 
extent by EMS (Freese, 1961; Freese and Freese, 1966)). 
MOLECULAR MECHANISM OF EMS-INDUCED MUTATION 
EMS reacts with guanine, adenine, cytosine and 5-hydroxymethyl-
cytosine when the free bases or nucleotides are exposed in solution (Brookes 
and Lawley, 1960, 1962; Pal, 1962). The reaction of this agent with DNA 
produces 7-ethylguanine and 3-ethyladenine and other products may be 
formed to a lesser extent. Two distinct mutagenic mechanisms have been 
postulated for 7-ethylguanine formation by EMS and one mechanism for 3-
ethyladenine (Pal, 1962). 
^. GC To AT transition mediated by ettiylguanine pairing errors: The guanine 
has a pk of 9.2 for the dissociation of the hydrogen at the N^  position, 
whereas the corresponding pk for a 7,9-substituted guanine is shifted closer 
to 7 ( Lawley and Brookes 1961). Thus, ionization of the N, may occur while 
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the DNA strand is serving as a template for DNA synthesis which would 
permit pairing of 7-ethylguanine with thymine (Fig. 5A) as well as with 
cytosine. This would generate a GC to AT transition. If a template molecule 
of 7-ethylguanine was not ionized at the moment of DNA replication it would 
pair like guanine with cytosine and hence make a normal, non-mutated 
copy. 
2. AT TO GC transition mediated by 3-ettiyladenine: 3-Methyladinosine 
has been shown to have an imino group in place of the amino group of 
adenine and to be positively charged at pH 8 and below (Pal, 1962). The 
presumed structure indicates that during DNA replication, pairing would be 
possible between 3-ethyladenine and cytosine by two hydrogen bonds (Fig. 
5B) and that pairing with thymine would not occur. 
SCOPE OF THE WORK 
The group I introns are subjected to undergo self-splicing reaction which 
is close to the action of ribozyme (Cech, 1987; Michel and Westhof, 1990). 
The studies on the T4 introns have also revealed, that the mode of catalytic 
action of these introns are similar to that of other group I introns (Hall et al, 
1987; Lai and Hall, 1993, 1997) Ribozymes are small RNA molecules en-
dowed with endonuclease activity at enzymatic rate (Symons, 1992, 1994; 
Tusch et al, 1995). Upon formation of a complex with their complementary 
target RNA , cleavage takes place leading to degradation of the target, on 
the other hand, antisense oligodeoxyribonucleotides similarly complex with 
RNA but, instead, inhibit translation (Fig. 6). Tetrahymena ribozyme is well 
characterized by P4-P6 structural domain which is an independently fold-
ing domain of intron tertiary structure (Wang et al, 1993). This P4-P6 
domain was measured as 2 8 A" crystal structure (Gate et al, 1996). 
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Six naturally occurring ribozyme structures have been identified. Cech 
(1987) described the Tetrahymena ribozyme which belongs to the 
Tetrahymena group I intron. This molecule is capable of autocatalytic cleav-
age during the RNA splicing process in Tetrahymena. A second ribozyme 
structure was elaborated by Guerrier-Takada et al (1983) during experi-
ments which characterized the structure of ribonuclease P. RNAse P is an 
endonuclease capable of cleaving the 5' end of pre-transfer RNA molecules 
during the maturation process leading to the formation of functional tRNA. 
Of the two subunits which comprise this molecule, Ml-RNA bears the cata-
lytic properties. Augmentation of the endonuclease activity appears to be 
the function of the 14 KD second subunit. A third type of ribozyme was 
identified in the minus-strand of satellite RNA of the tobacco ringspot virus 
(Hampel and Tritz, 1989; Hampel et al, 1990; Mitchell et al, 1992). Owing to 
the characteristic hairpin like structure formed upon hybridization of the 
cataytic domain, consisting of 50 nucleotides with the substrate strand, it is 
referred to as hairpin ribozyme. Hammerhead ribozymes (Uhlenbeck, 1987), 
a fourth class of ribozymes , have a common secondary structure consist-
ing of 3 stem structures flanking a conserved single-stranded region which 
possesses catalytic activity. It has been identified in plant viroids, virusoids 
and satellite viruses. Two additional catalytically active ribozyme motifs have 
been described in hepatitis delta virus and in Neurospora (Xu and Shub, 
1989). 
This enzymatic activity of group I introns and ribozyme heralded a new 
era in the field of modern medicine. The natural activity of ribozymes in-
volved a single intramolecular cleavage reaction designated as cis-reac-
tion because of the presence of the both enzyme and substrate within the 
same molecule. By separating the hammerhead ribozymes through the re-
26 
moval of naturally occurring loop in the stem structures, Forster and his 
associates as well as Uhlenbeck in 1987 have demonstrated trans reaction 
which allows for the turn over of the several substrate molecules. The con-
trol of expression of specific gene is an application of ribozyme technology 
which is of particular interest. Because of its small size, the catalytic core 
of hammerhead ribozyme can be integrated into RNA or DNA structures 
and subsequently cleave their target. 
This catalytic activity of ribozyme is being exploited for the inhibition 
of the replication of human immunodeficiency virus (HIV) through the inac-
tivatlon of viral RNA with ribozymes{Sarvaretal, 1990; Dropulicetal, 1992). 
Besides that, the hairpin and hammerhead ribozymes containing a 
5'C(UUCG)G3' loop were designed to cleave the long terminal repeat of 
HIV-I (Koizumi et al, 1995). As it is an established fact that hepatitis C virus 
(HCV), a positive strand RNA virus is the major infectious agent responsi-
ble for causing chronic hepatitis. Currently, there is no vaccine for HCV 
infection. To investigate the utility of the ribozyme technology for the man-
agement of HCV infection, six hammerhead ribozymes directed against a 
conserved region of the plus strand and minus strand of HCV genome were 
isolated. The expressed ribozyme individually or in combination were effi-
cient at reducing or eliminating the respective plus- or minus- strand of 
HCV RNA expressed in culture cells and from chronic HCV infected pa-
tients (Lieber et al, 1996). 
Ribozyme is thought to be a powerful tool for the suppression of spe-
cific gene expression, but there are many failures under In vivo conditions. 
One reason may be that there are many cellular proteins in vivo which may 
inhibit the catalytic activity of ribozymes (Koguma et al, 1995; Junn and 
Kang, 1996). Therefore, to achieve a successful trial in vivo a chemical 
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synthesis of RNA has been designed which has several advantages over 
synthesis by "atomic mutagenesis" in which individual atoms or chemical 
groups are altered or removed by the site-specific incorporation of nucleotide 
analogs. Advances in the solid-phase chemical synthesis of RNA have al-
lowed the complete chemical synthesis of small ribozymes, including 19-
and 35- nts hammerhead ribozyme (Perrault et al, 1990; Scaringe et al, 
1990) and 59-nts hairpin ribozyme (Vinayak et al, 1992). The small sized 
synthetic ribozymes are easy to deliver through liposome technology. 
These developments in the ribozyme technology may be challenging 
to the scientists working on the synthesis of vaccines against HIV and 
other RNA viruses. 
DETAILED OBJECTIVES OF THE WORK 
In view of the available literature, we initiated the work on the screen-
ing of T4 nrdB mutants to study the structural functional relationship in the 
RNA splicing of group I introns as a model to understand the requirements 
of secondary and tertiary structure of RNA in the autocatalytic cleavage of 
introns. The focus of the research was, therefore, to address the problem 
on the following lines: 
(1) Isolation and screening of the EMS-induced f^d^ double mutants by us-
ing a novel technique of halo phenotype. 
(2) Mapping of f^d^nrdB mutants with the help of recombination based 
marker rescue technique with various clones and sub-clones carrying the 
whole nrdB gene, nrdB intron, as well as carrying various subregions of 
mtron. 
(3) Dot blot hybridization splicing assay of the RNA preparations of the 
mutants by using various probes to analyse the splicing defective point 
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mutations. 
(4) EMS-mutagenesis of frcl^n^clB double mutants. 
(5) Isolation and mapping of intragenic and extragenic revertants of frd^ nrdB 
mutants. 
(6) Dot blot analysis of those revertants. 
(7) Elucidation of secondary and tertiary structure responsible for RNA 
splicing taking advantage of the characteristics of the splicing defective 
mutants and their revertants. 
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Figure 1: Splicing mechanism of the four major groups of precursor RNAs. 
Wavy lines indicate intron, smooth lines indicate flanking exons. For nu-
clear mRNA splicing, many components assemble with the pre-mRNA to 
form the sp l iceosome; only two, the U1 and U2 small nuclear 
ribonucleoproteins, are shown [Cech, 1990]. 
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Figure 2: A Typical structure of group I intron, according to the 
convention of Burke et al (1987). (a) Conserved sequence elements P, Q, 
R, and S are represented by their most common nucleotide sequences. 
Dashed line between P4 and P6 was added to make the diagram less 
crowded; no nucleotides have been omitted here. Filled arrows, 5' and 3' 
splice sites; Open arrow, site of insertion of extra stem-loop(s) P7.1 and 
P7.2 in group lA intron. (b) Secondary structure of T. thermophila intron 
with base-paired regions. 
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Figure 3: Splicing mechanism of group I introns, and trans-esterification 
reaction, the first step in the splicing of group 1 introns in which the 3' OH of 
guanosine molecule acts as nucleophile. 
The 3' OH of the S'exon 
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Figure 4: Secondary structures for intron sequences from the nrdB, td and 
SunYgenes, (waring and Davies, 1984). 
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Figure 5: Pairings postulated to occur during replication of DNA containing 
ethylated purines. Hydrogen bonds are shown by dotted lines. A, 
7-ethylguanine and thymine; B, 3-ethyladenine and cytosine. 
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Figure 6: Ribozyme versus antisense-RNA-mediated inhibition of mRNA 
expression. The targeted messenger base pairs with either (a) the antisense 
RNA or (b) the ribozyme [Rossi, 1995] 
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CHAPTER IL General materials and metkods 
CHEMICALS 
The following chemicals were used: 
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MATERIALS: 
Acetic acid 
Acrylamide 
Agar agar 
Ammonia aqueous 
Ammonium chloride 
Ammonium persulphate 
Bis-acrylamide 
Boric acid 
Bovine serum albumin 
Bromophenol blue 
Calcium chloride 
Casein hydrolysate 
(Vitamin free) 
Chloramphenicol 
Chloroform 
Cytidine 
Diethylpyrocarbonate (DEPC) 
Dithiothereitol (DTT) 
DNase free pancreatic RNase 
Ethanol (Absolute alcohol) 
Ethedium bromide 
Ethylenediamine tetra-acetate 
Ethylmethane sulphonate (EMS) 
SOURCES 
SRL, India 
Amresco, USA 
Hi-Media, India 
Fluka, USA 
SRL, India 
Serva Feinbiochemica, Finland 
Amresco, USA 
E.Merck, India 
Sigma, USA 
Bio-Red, USA 
SRL, India 
Difco Laboratories, USA 
Ranbaxy, India 
SRL, India 
Sigma, USA 
Sigma, USA 
Sigma, USA 
Promega, USA 
E.Merck, India 
Sigma, USA 
SRL, India 
Sigma, USA 
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Ficol 
Formaldehyde 
Formamide 
Glacial acetic acid 
Glucose 
Glycerol 
P-Glycerophosphate 
Hydrochloric acid 
8-hydroxyquinoline 
Isoamyl alcohol 
Liquid nitrogen 
Lysozyme 
Magnesium acetate 
Magnesium chloride 
p-mercaptoethanol 
Nutrient broth 
Phenol 
Polyvlnylpyrrolidine 
Potassium chloride 
RNase free DNase I 
RNAsin 
Sodium acetate 
Sodium chloride 
Sodium citrate 
Sodium dodecyl sulphate ( S D ^ 
Sodium hydroxide 
Sodium phosphate 
Sigma, USA 
Sarabhai.M.Chemical, India 
SRL, India 
E.Merck, India 
Qualigen, India 
SRL, India 
Sigma, USA 
SRL, India 
Sigma, USA 
SRL, India 
ICGEB, India 
Sigma, USA 
SRL, India 
SRL, India 
Sigma, USA 
Hi-media, India 
SRL, India 
Sigma, USA 
SRL, India 
Promega, USA 
Promega, USA 
SRL, India 
Hi-Media, India 
SRL, India 
SRL, India 
SRL, India 
SRL, India 
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MEDIA 
The composition of the GPTG medium is as under: 
p-Glycerophosphate 
NaCI 
KCI 
CaClj 
MgClj.e HP 
NH^CI 
Trizma (tris) base (pH 7.4) 
Na^SO, 
Glucose (50%) 
Vitamin free Casein Hydrolysate (10%) 
d,H,0 
10g/l 
5.8 g/l 
3.7 g/l 
0.11 g/l 
0.1 g/l 
0.1 g/l 
12.1 g/l 
0.14 g/l 
10 ml 
10 ml 
980 ml 
1. For GPTG plates 15 g of agar-agar was added, autoclaved and then 20 
ng/ml of tryptophan and cytidine was added. 
2. For top agar concentration of agar-agar was reduced to half (7.5%). 
Nutrient Broth: 
Peptone 5 g/j 
NaCI 5 g/l 
Beef extract 1.5 g/l 
Yeast extract 1.5 g/l 
pH (approx.) 7.4 
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Soft Agar: 
Nutrient broth 13g/l 
Agar-agar 7 g/l 
Hard Agar: 
Nutrient broth 13 g/l 
Agar-agar 14 g/l 
Solutions for RNA extraction: 
Solution I: 
lOmM Tris-HCI(pH 7.5) + ImM EDTA 150 1^ 
1M Dithiothereitol 1.5^1 
20 U/^l RNasin 1.5^1 
10 mg/ml Lysozyme 4.0 1^ 
Solution II: 
1M MgACj 
13 mg/ml RNase free DNase 1 
20 U/^l RNasin 
DEPC-treated Water 
20.0 ^1 
17.5 Hi 
1.00^1 
61.5^1 
Solutions for oligonucleotide End-labeling: 
Tris-EDTA buffer (TE): 
Tris-HCI 10 mM 
EDTA 1.0 mM 
pH 7 5 
40 
5X Kinase buffer (5X KB): 
Dithiothereitol (DTT) 25 mM 
MgCI^ 50 mM 
Spermidine 1.0 mM 
Tris-HCI 0.5 mM 
pH 8.0 
Diethyipyrocarbonate-treated water: 
DEPC 0.1% (v/v) 
Solutions for hybridization: 
Prehybridization mix: 
Formamide 50% 
SSPE 5X 
Denhardt's reagent 2X 
SDS 0.1% 
SSC (20X): 
NaCI 3.0 M 
Na-Citrate 3.0 M 
pH 7.5 adjusted with 10N NaOH 
Denhardt's solution (50X): 
Ficol 400 5 g 
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Polyvinylpyrrolidine 
BSA 
DEPC Water 
SSPE (20X): 
NaCI 
NaHjPO, 
EDTA 
H,0 
pH 7.4 was adjusted with NaOH, 
5 g 
5 g 
500 ml 
175.3 g 
24.6 g 
7.4 g 
800 ml 
volume make to 1000 ml 
Composition for extraction buffer: 
NaCI 0.5 M 
Tris 20 mM 
EDTA 1 mM 
pH (8.0) 
Solutions for DNA mini-preparation: 
Solution I: 
Glucose 50 mM 
Tris-CI 25 mM 
EDTA 10 mM 
pH (8.0) 
Solution II: 
NaOH 0.2 
SDS 1 % 
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Solution III: 
Potassium acetate 5 M 
Glacial acetic acid 11.5 ml 
HjO 88.5 ml 
Phage and Bcterial Strains: 
T4Do, an osmotic shock resistant mutant of T4D was used as standard 
(wild type) T4. 
The f^d^ mutant was isolated from T4Do strain after Hydroxylamine 
mutagenesis exploiting the white halo phenotype on the OK305 strain of 
E.coli B . A series of frd^nrdB double mutants was used for isolation of 
revertants . 
Bacterial strains and plasmids: 
E.coli B cells were used for phage crosses. E. coli BB cells were used 
for prepa'-ation of phage lysates (stock). Genetic selection and screening 
for T4 td, frdi and nrdB mutations were routinely performed by plating sus-
pected mutants on E.coli OK305 cells. OK305 is uracil-requiring E.coli B 
mutant that has very low cytidine deaminase activity and no detectible 
deoxycytidine deaminase activity. E.co//JM101 and JM109 strains are F* 
strain suitable as hosts for M13mp10 phage infection. JM109 Thy A is a 
thymine- requiring JM109 derivative isolated in the laboratory of Marlene 
Belfort, SUNY, Albany, NY. 
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The nrdB series of plasmid subclones used for marker rescue experi-
ments were obtained by cloned fragments of the T4 nrdB gene into plasmid 
pBSM13* (Stratagene) followed by transformation of the plasmid insert con-
struct into JM101 and JM109. The nrdB subclone library was constructed in 
the laboratory of Dr. David Shub, SUNY, NY. 
LIST OF RECOMBINANT CLONES 
Plasmid 
pJSSIO 
pJBK1 
pJG106 
pJG108 
pJSK7 
pJSR1 
pJBS1 
Size 
4.6 Kb 
3.9 Kb 
3.8 Kb 
3.6 Kb 
3.3 Kb 
3.5 Kb 
3.4 Kb 
Cloned reoion 
nrdB gene 
nrdB intron 
A+B region of intron 
C+D region of intron 
D region of intron 
B region of intron 
A region of intron 
METHODS 
Maintenance and growth of bacterial strains: 
Each strain of E.coli was streaked on a nutrient agar plate. A single 
colony was picked up from the plate and repurified again by streaking. The 
culture was tested on the basis of associated genetic markers raising it 
from a single colony on the master plate. Having satisfied with the test clone, 
44 
the culture was streaked on nutrient agar slants. It was then allowed to 
grow overnight at 37°C and stored at 4''C. The culture was transferred on 
to the fresh slants every month. 
Stab preparation: 
Stab cultures were also prepared from the cultures originated from the 
single colony of checked associated marker. These stabs were stored at 
4°C for a year or so. 
Gycerol culture: 
Glycerol cultures were made by mixing 0.8 ml of freshly grovm over-
night cells into 0.2 ml of 15% sterilized glycerol. It was preserved at -JO'C 
for several years. 
PREPARATION AND PRESERVATION OF PHAGE STOCKS 
Lysate preparation: 
Over night Liquid Lysate: Over night liquid lysates were used for general 
phage stocks and usually yielded a titre of 1x1C to 1x10^" plaque forming 
units per ml (PFU/ml). Over night liquid lysates were prepared by inoculat-
ing 5 ml of liquid broth medium with either a freshly picked plaque contain-
ing approximately 10^ FPU or 10^ phage particles from another stock. A 
0.1 ml of fresh, full grown E. coli BB cells were added to the broth contain-
ing the phage and the tube were incubated at 37°C in a dry air incubator for 
15-19 hours. The lysate were then chloroformed (12 drops) and allowed to 
sit ai room temperature for 15 minutes before dilution and titre 
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determination. The lysate was stored at 4'C. 
Plate Lysate: High titre phage stocks were made using plate lysates 
which yielded a titre of 1x10^° to 1x10" PFU/ml. Approximately 2x10^ phage 
particles and 2-4x10" E. coli BB cells were added to top agar and subse-
quently poured onto the LB agar plate. The LB medium was used for mak-
ing plate lysates. Plates were incubated at 37°C for 12-14 hours at which 
point the plaques were partially confluent on the plate with only little of the 
cell lawn remaining visible. One ml of chloroform was spread over the top 
of the plate so that the entire surface of the plate was covered with chloro-
form. After the chloroform dried on the plate, 3ml of LB was poured over 
the top of the plate. The plate was briefly swirled at room temperature by 
hand every half an hour or so for three hours before the LB medium was 
collected from the top of plate with pasteur pipette and placed in a 15 ml 
corex centrifuge tube. In some cases two or three plates were made for 
each phage stock so that the final volume of high titre lysate approached to 
10 mis. All plate lysates were centrifuged for 15 minutes at 7000 rpm in a 
Sorvell SS-34 rotor at 4°C. The supernatant was collected and few drops of 
chloroform were added. This lysate was stored at 4°C. 
Bubbling Lysate Technique: Large (20 ml) bubbling lysates were pre-
pared by using a large bubbling tube containing 20 ml of LB media, inocu-
lated with 0.8 ml cells from a fresh over night culture of E. coli B or BB and 
aerated at 37°C until the cells were reached 1 to 2 X 10*/ml. The culture 
was then inoculated with 2 to 4 X 10^ phage particles from a stock lysate or 
with 1 ml of a 2 ml fresh plaque picking in diluting fluid. Aeration at 37°C 
continued until the lysate cleared, no longer than 5 hrs. At that point 1 ml of 
chloroform was added with aeration at 37°C continuing for an additional ten 
minutes. The lysate was transferred to a 45 ml polypropylene tube and 
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centrifuged at 7000 rpm in Sorvall SS-34 rotor for 30 min at 4»C to pellet 
down the cell debris. The supernatant was carefully decanted and saved. 
After addition of several drops of chloroform, the lysate was diluted, as-
sayed and then stored at 4°C. The titre was typically between 10^° and 10" 
plaque forming units per ml. 
Mutagenesis: 
frd^ mutant of T4 phage was further mutagenized by EMS. A 0.2 M 
solution of EMS was mixed with 12.5 % ethanol which was then incubated 
along with the equal volume of T4 frdi mutant for 2 hours at SZ'C followed 
by diluting it upto 10 volumes of nutrient broth, containing Na2S203. This 
reaction mixture was further incubated for 24 hours at ST^C (Drake and 
Greening, 1970). 
Phage plating conditions: 
In general phages were visualized as plaques on agar plates by either 
one of the two methods mentioned below. 
(i) Adding phage and E.coli cell to 2.5 ml of top agar prior to spreading the 
agar on an agar plate. 
(ii) Spotting a small volume of phage (30 ml) on an agar plate seeded with 
the host bacteria. After plating or spotting of phage, plates were usually 
placed in a 37''C incubator for over night (10-14 hours) and the plaques 
were observed the next day. 
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td/fr& plating conditions: 
T4 mutants defective in thymidylate synthase production {td') or de-
fective in dihydrofolate reductase production {frd') were screened by as-
saying for a wtilte halo plaque phenotype. 
White halo plaque phenotype: 
The white halo appears around a plaque, under special plating condi-
tions with E.coli OK305 cells which have defect in their de novo cytidine 
deaminase activity and deoxycytidine deaminase activity. When a lawn of 
OK305 was grovwi on petri dishes with synthetic medium (GPTG) (Hall et 
al, 1967) containing cytidine as a sole pyrimidine source, there was thus a 
dUMP deficiency which could be remedied if the cells were infected with a 
mutant defective either in dTMP synthase {td') or in dihydrofolate reductase 
{fr&). Both mutants cause dUMP accumulation which can leak from infected 
cells and feed neighbouring cells. This causes mutant plaques to be sur-
rounded by a white halos. 
Phage particles were plated with 2x10» E. coli OK305 cells on 
GPTG+CR plates (GPTG plates with 20ng/ml CR added to the agar before 
plate pouring) supplemented with 4 i^l of CR (10 mg/ml) added to the top 
agar for each plate. After the top agar hardened, plates were incubated at 
37°C for 8-10 hours. Plates can be incubated at 37''C for a sl^prt pefiod of 
time. Generally, frd^ mutations result in a stronger yvhite halo than do td 
mutation. 
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nrdB- plating condition: 
A second mutation in the td' or frdV T4 phage in either of the nrdB 
gene , the cd gene or gene 56 will result in the disappearance of the halo 
which was present when there was only the initial td' or frdi' mutation. To 
isolate nrdB- mutant phage, 2x10» OK305 cells ,40ng of CR along with frd/ 
td- phage that had been mutagenized for a second mutation were added to 
GPTG top agar and then poured on to GPTG+CR agar plates. T4 nrdB', od-
or gene 56 mutants carrying the initial frd/td mutation, did not exhibit the 
white halo phenotype under these conditions while nrdB* phage, wild type, 
td- and f^d^^ phage did produce a white halo. 
Plasmid mini-preparation: 
For mini preparation of plasmid DNA, a slightly modified procedure for 
rapid alkaline extraction method of Birnboim and Doly (1980) was followed. 
Harvesting: 
A single colony was transferred into 2 ml of LB medium containing the 
appropriate antibiotic in a loosely capped 15 ml tube. The culture was incu-
bated overnight at 37°C with vigorous shaking. Then 1.5 ml of over night 
culture was poured into microfuge tube followed by centrifugation at 14000 
rpm for 30 seconds at 4°C in microfuge. The medium was removed leaving 
the bacterial pellet as dry as possible. 
Lysis by alkali: 
Bacterial pellet was resuspended in 100^1 of ice cold solution I (as 
described in general materials and methods) by vigorous vortexing. A 200|al 
of freshly prepared solution II was added followed by inversion of the tubes 
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rapidly five times (vortexing not allowed). Then 150|il of ice cold solution III 
was added and gentle vortexing was done for 10 seconds. The tubes were 
then stored on ice for 3-5 minutes followed by centrifugation at 14000 rpm 
for 5 min at 4°C in a microfuge. The supernatant were transferred to fresh 
tubes. An equal volume of phenolxhioroform was then added and it was 
mixed by vortexing and centrifuging at 14000 rpm for 2 min at 4'»C in 
microfuge. The upper layer was transferred to fresh tube. DNA was precipi-
tated in 2 volumes of ethanol at room temperature. It was then mixed by 
vortexing followed by incubation of the mixture at room temperature for 2 
min. The mixture was centrifuged at 14000 rpm for 5 min at 4°C in a 
microfuge. The supernatant was discarded and the pellet of DNA was 
washed twice with 1 ml of 70% ethanol at 4''C. The pellet thus obtained was 
air dried, and dissolved in TE (pH 8.0). 
Transformation of E.coli cells with pJSSIO, pJBK1, pJG106, pJGIOS, 
pJSRI, pJBSI and pJSK7 plasmid DNA: 
The transformation of these plasmids carrying clones of nrdB gene 
and its various intronic regions was carried out into the JM101 cells. 
Preparation of competent cells: 
A single colony of JM101 strain was picked from a freshly grown plate 
and inoculated into 50 ml of Luria broth in a 250 ml flask. The cells were 
grown with vigorous shaking at 37°C for about 3 hours and growth was moni-
tored at 600 nm (density should not exceed 10'cells/ml). These cells were 
then transferred to a pre-chilled sterile 50 ml polypropylene tube and stored 
on ice for about 10 min followed by centrifugation at 4000 rpm for 10 min at 
4°C The cell pellet was thoroughly washed once with chilled 50 mM CaCI^ 
and resuspended again in 30 ml of the CaClj solution. The cells were kept 
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on ice for 1 hour followed by centrifugation in cold and resuspended in 1 ml 
of the ice-cold CaClj solution. 
Transformation of competent cells: 
20[i\ plasmid and 200^1 competent cells were added with 100^1 of 
lOOmM tris-CI, pH 7.5, which was then incubated on ice for 30 min Heat 
shock was given to cells 42°C for 2 min. It was chilled on ice for 5 min, 
centrifuged at 4000 rpm for 5 min at room temperature and supernatant 
was discarded. Cells were resuspended in 1 ml of fresh LB and incubated 
at ST^C for 1 hr. Again it was centrifuged at 4000 rpm for 2 min. 100^1 of 
fresh LB was added, resuspended and spread on a LB plate containing 
antibiotic. Grown overnight at dVC. 
Marker rescue mapping procedure: 
Marker rescue: 
The recombination based marker rescue technique was used to map 
nrdB mutations. Marker rescue was said to be positive if a mutant phage 
was infected into a cell which had a corresponding wild sequence for that 
mutation in the phage genome. Some percent of the progeny phage would 
have picked up this wild type sequence from the cell and thus showed wild 
type phenotype. Using this principle, the nrdB' (non-halo) mutants were iden-
tified by infecting host cells containing a cloned nrdB gene and looking for 
nrdB* (halo*) progeny in the marker rescue lysate. Identification of intron 
mutants and their finer mapping was also conducted using the same princi-
ple of marker rescue by using a series of intron subclones of the nrdB gene. 
51 
Isolation and purification of EMS-induced mutants: 
EMS mutagenized frc/1 mutants of T4 phage were plated under the 
GPTG condition with OK305 cells. Halo' plaque was picked and suspended 
in 1 ml of diluting fluid. This isolated plaque was tested for purity and hence 
those plaques were picked that did not show any halo"^  character even if 
10,000 plaques were screened. A purified well isolated hale plaque was 
preserved in diluting fluid with a few drops of chloroform and this lysate 
was used to prepare a high titre lysate for further studies. 
Isolation of nrdB mutants: 
EMS mutagenized frc/1 mutants of T4 phage was infected on JM101 
cell containing the clone of nrdB gene. The cells with phage were plated on 
to the nutrient agar plate. After the incubation of several hours at ZT'C, 
plaques were appeared. Two well isolated plaques were picked and each 
dissolved in 1 ml of diluting fluid. A few drops of chloroform were added and 
preserved at 4''C. This isolate was then tested for halo phenotype under the 
GPTG plating conditions with OK305 cells. The strategy was that, if it showed 
halo* phenotype (>5%) then the mutant stock was said to be nrdB mutant. 
Mapping of nrdB intron mutants: 
Phage stocks from the nrdB mutants were diluted appropriately and 
plated on nutrient agar with JM101 cells containing the pJBK1 clone carry-
ing the nrdB intron. For each one of the marker rescue plates, two well 
isolated plaques were picked into 1 ml diluting fluid and three drops of chlo-
roform were added to kill the cells. Serial dilutions were made and tested 
for halo* phenotype. Appropriate controls with f^d^ mutant and wt phage 
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were plated for comparison with marker rescue plates. A minimum of 10^ 
plaques were screened for each marker rescue. The recombination based 
marker rescue technique was said to be positive if a mutant phage was 
infected into a cell which had a corresponding wt sequence for that muta-
tion in the phage genome. Some percent of progeny phage would have 
picked up this wt sequence by recombination with the insert in the plasmid 
and thus showed wt (halo*) phenotype. 
Mapping of sub-regions of the nrdB intron mutants: 
Phage stocks from the nrdB mutants were diluted appropriately and 
plated on nutrient agar with JM101 cells containing the pJG106 carrying 
A+B region of intron. For each marker rescue plates two well isolated plaques 
were picked into 1 ml diluting fluid and three drops of chloroform were added 
to kill the cells. Serial dilutions were made and tested for halo* phenotype. 
Appropriate control with f^d^ mutant and wt phage were plated for compari-
son with marker rescue plates. A minimum of 10^ plaques were screened 
for each marker rescue. The recombination based marker rescue technique 
was said to be positive if a mutant phage was infected into a cell which had 
a corresponding wt sequence for that mutation in the phage genome. Some 
percent of progeny phage would have picked up this wt sequence by re-
combination with the insert in the plasmid and thus showed wt (halo*) phe-
notype. Similar experiments were performed for the mapping of remaining 
region of intron with different subclones of nrdB intron. The pJG108 was 
used for mapping the mutants within C+D region, pJBS1, pJSR1, and pJSK7 
were used for the mapping of A,B, and D region of intron respectivey. 
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RNA preparation: 
E. coli BB cells from a freshly grown culture were diluted 100-fold into 
Luria broth and the culture was allowed to grow again at 30°C in a shaking 
water bath until the cell density reached to 2x10" cells/ml. The cells were 
transferred to 50 ml Oak Ridge centrifuge tube and centrifuged at 10,000 
rpm for 10 min at 4°C. The cells were resuspended in 0.5 ml LB followed by 
the addition of the infecting phage and placed the tubes on ice for 5 min. 
Cells were usually infected with a phage multiplicity of infection (MOI) of at 
least seven. The cell/phage mixture was added to 30 ml of pre-warmed (30°) 
LB and Incubated at 30°C for 9 minutes in shaking water bath. 1.2 ml of 
chloramphenicol was added at 2.5mg/ml and placed the cells at 30° for one 
minute. The flask containing the culture was then rapidly cooled in an ice-
water bath until the temperature of the culture had reached 4°C. The cells 
were then transferred to pre-chilled centrifuge tubes and spun at 10,000 
rpm for 10 min at 4°C followed by resuspension in one ml of 10 mMtris (pH 
7.5)-CAM (100ng/ml) solution without vortexing. These were then trans-
ferred to 1.5 ml eppendorf microfuge tube and centrifuged at 4^ C for 2 min. 
Supernatant was discarded and resuspended the cells pellet by vortexing 
in 0.5 ml of the Tris-CAM solution. It was again centrifuged for 2 min and 
supernatant was discarded. The pellet was blotted with tissue paper, fol-
lowed by freezing the pellet in liquid nitrogen. It was used immediately or 
stored at -80°C for upto a month. 
RNA Extraction: 
A 157^1 of solution I (as described in the methods section) was added 
to the frozen pellets and resuspended (vortexing allowed at this stage). 
The suspension was quickly frozen and thawed three times in liquid 
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nitrogen and then 20^1 of solution II was added . The mixture was shaken 
gently and placed on ice for 45 min. Then 10^1 of 0.2% acetic acid and 10^1 
of 10% SDS was added. The tubes were placed at room temperature for 5 
min. Three series of organic extractions were usually performed with phe-
nol / chloroform / isoamyl alcohol in a 25:24:1 ratio using phenol, buffered 
with 0.1 M tr is-HCI pH 7.5, 0 .1% 8-hydroxyquinoline and 0.2% 
mer^aptoethanol . The tubes were centrifuged for 3 min at 14000 rpm at 
4°C. The aqueous (top) phase was saved into fresh eppendorf tube and 
used for the second extraction. Tha second extraction was carried out by 
chloroform / isoamyl alcohol in 24:1 ratio. Again the top phase was saved 
(after centrifugation as above) for the third extraction. After third extrac-
tion, approximately 100^1 was transferred to a new 1.5 ml tube and 1/100th 
volume of 1M MgAc^, 1/10th volume of 3M NaAc (pH 5.2) and 2.5 ml of 
100% ethanol was added. Precipitation of RNA was allowed to occur at 
-SO C^ for at least one hour or -20''C for over night. Tubes were then centri-
fuged at A^C for 20 minutes. The pellet was then resuspended in lOO i^l of 
DEPC-treated water followed by the addition of 1 i^l of 1M MgACj ,1 O^ il of 3M 
NaAc (pH 5.2) and 2.5 ml of 100% ethanol. Again it was precipitated at 
-20'>C or -80°C followed by centrifugation. The pellet was washed with 70% 
ethanol and dried in vacuum. The pellet was resuspended in appropriate 
volume of DEPC-water. RNA concentration was measured at 260 nm by 
making dilution. A concentration factor of 1 OD^^ = 40|j,g/ml RNA. 
End-labeling of synthetic oligonucleotides: 
5'-End labelling of oligonucleotides with Y'^^P-ATP was performed. 
Twenty picomoles of purified synthetic oligonucleotide , 1.0^1 of T4 
polynucleotide kinase at (10 U/^l), 2.0^1 of 5X Kinase buffer, O.Sjxl of DEPC-
treated water and 4.2^1 of y'2p_Ajp(3ooo ci/mM) were added to a 1.5ml 
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tube. The kinase mixture was incubated a 30°C for 45 minutes followed by 
incubation at SS'C for 3 min. After cooling on ice, 25|il of DEPC-treated 
water was added. 
Urea-PAGE obtained by 8% acrylamide / bis-acrylamide and 7M urea 
was run for 15-20 minutes followed by the exposure on X-ray film, the band 
was cut from the gel and oligo was eluted in the extraction buffer. The solu-
tion was filtered via siliconized glass wool. 
Dot blot hybridization: 
A piece of Hybond membrane was completely soaked in water for 10min 
and then soaked in 20X SSC solution for one hour at room temperature. 
Mean while the manifold hybridization apparatus was cleaned with 0.1 N 
NaOH and then rinsed it well with sterile water. All the slots were filled with 
10X SSC, and a gentle suction was applied until all the fluid has passed 
through the membrane filter. The sample was prepared by mixing the RNA 
with 20^1 of 100% formamide, 7^1 of 37% formaldehyde ,2^1 of 20X SSC, 
the mixture was then incubated for 15 minutes at 6B°C and then it was cooled 
on ice. It was then loaded into separate slots and gentle suction was ap-
plied . Each slot was rinsed with 1 ml of 10X SSC after all the samples have 
passed through slots. The membrane was dried at room temperature, and 
crosslinked under the UV light. v >.,---—s_^ 
« QQ. H o 
Hybridization and autoradiography: • \ _^ /^A/^9 .•-' 
The filter was prehybridized for one hour in the mixture of 50% 
formamide, 5X SSPE ,2X Denhardt's reagent and 0.1 % SDS at 42°C. Dena-
tured radiolabeled probe was added directly to prehybridization fluid. To 
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detect the low abundance mRNA, 0.1 ^g of probe was used, wtiose specific 
activity exceededl2x10" cpm/ng . Incubation was continued for 16-24 hours 
at 42'*C. Then the filter was washed for 20 min at room temperature in IX 
SSC with 0.1% SDS followed by three washes of 20 min each at 68" C in 
0.2XSSC with 0.1% SDS . 
An autoradiogram was obtained by exposing the membrane for ap-
propriate period of time. 
C H A P T E R Ills Isolation and mapping of 
jh/jyio maucea. splicing deiective point mutations 
oi nrdlj intron oi oacteriopnage T 4 
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INTRODUCTION 
Bacteriophage T4 contains three self splicing introns, the td intron (chu 
et al, 1984), the nrdB intron (Sjoberg et al, 1986) and sunY{nrdD) intron 
(Gott et al, 1986). These introns differ substantially both in sequence and 
in size. The nrdD and td introns respectively comprise 1033 and 1016 
nucleotides while the nrdB intron is only 598 nucleotides long. 
The white halo plaque phenotype exhibited by frd^ mutants under spe-
cial plating conditions (Hall and Tessman, 1967) is an excellant system for 
the Isolation of nrdB mutants which can be characterized further for intron 
mutants by using the nrdB intron subclones to rescue the intron mutation. 
We have mutagenized frd1 mutants by in vitro ethylmethane sulphonate 
treatment ( Drake and Greening, 1970). Using this approach a number of 
frd^n^dB double mutants were isolated. In the previous study Lai and Hall 
(1993) used hydroxylamine as a mutagenic agent which is specific to 
cytosine, whereas EMS is non-specific alkylating agent that causes bidi-
rectional transition i.e. AT to GC as well as GC to AT. EMS reacts with 
guanine, adenine, cytosine and 5-hydroxymethylcytosine when the free 
bases or nucleotides are exposed in solution (Brookes and Lawley, 1960, 
1962). The reaction of this agent with DNA produces 7-ethylguanine and 3-
ethyladenine and other products may occur to a lesser extent (Brookes and 
Lawley, 1962). 
The pJSSIO clone carrying whole nrdB gene was used to isolate the 
nrdB mutants. The intron sequence along with 80 bases from 3'-end of the 
exon I and 4 bases from 5'-end of the exon II, cloned in pJBKI was used to 
map the nrdB mutants within the short stretch of intron. Region A+B of the 
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intron was mapped by using subclone pJG106. The remaining intron mu-
tants were mapped within C+D region by using the subclone pJG108. These 
two regions of intron were splitted into A,B,D, and C regions. The mutations 
were mapped within these regions by using subclones, pJBS1, pJSR1, and 
pJBK1 respectively. Region C does not have any clone, therefore, muta-
tions in this region were mapped by default. 
Intron of nrdB gene has a series of short conserved sequence ele-
ments P,Q,R and S. Interestingly, all the mutants isolated in this study clus-
tered into regions of the nrdB intron containing at least a portion of the 
P,Q,R,and S sequences. The frequency of homologous recombination (cross-
ing over occurs during the recombination of T4 mutant gene and wild type 
clone of the same gene) resulting in wild type phenotype has been used to 
predict the relative distances between various mutations. Dot blot splicing 
assay was also performed. 
METHODS 
The frd1 mutants of phage T4 was mutagenised by ethylmethane 
sulphonate (Drake and Greening, 1970). 
Isolation and mapping of nrdB intron mutants were performed on the 
basis of recombination based marker rescue technique (as explained in 
chapter II). In this chapter we have mutagenized the frd1 mutants which 
have halo* phenotype as described in the section of general methods. These 
frdi double mutants were then screened for purification and isolation of the 
nrdB mutants. The mapping was carried out by using recombinant plasmids 
containing the desired regions of nrdB intron and their sub-regions to be 
mapped. These recombinant plasmids were transformed into JM101 cells. 
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Subsequently the mutagenized f^d^ double mutants were diluted ap-
propriately and plated on LB plates with the recombinant clones (Fig. 6). 
For each one of the marker rescue plates, two well isolated plaques were 
picked into 1 ml of the diluting fluid and three drops of chloroform were added 
to kill the cells, several dilutions were made and tested for halo^ pheno-
type. Halo is excess growth of cells around the plaques due to accumula-
tion of uracil in frd^ mutants of T4 phage as described in general methods 
(Fig. 2). Appropriate control plates with frdV and wt phage were plated for 
comparison along with the test marker rescue plates. A minimum of 10* 
plaques were screened for each marker rescue. The recombination based 
marker rescue is said to be positive if a mutant phage infected a cell which 
had a corresponding vA sequence for that mutation in the phage genome. A 
fraction of the progeny phage would have picked up this wt sequence by 
homologous recombination from the insert in the plasmid and thus showed 
wt (halo*) phenotype. The mutant which does not show wt (halo*) pheno-
type with recombinant plasmid (not less than 5% halo* frequency) does not 
have any mutation within the region which have been cloned. 
The total RNA extraction was initiated after a 9 min Infection to maxi-
mize the amount of nrdB mRNA isolated from the selected f^d^nrdB T4 
mutant infected E.coli BB cells was performed as described by Lai and Hall 
(1997). RNA Dot blot hybridizations were also performed by using the pro-
tocol described by Belfort et al (1985). 
60 
RESULTS 
Determination of mutagen dosage: The mutagenesis experiment was 
performed to check the efficacy of the EMS and, therefore, various concen-
trations of EMS were taken to determine the appropriate dose of EMS 
which would give the survival and mutagenicity within the range of estima-
tion. The phage frd^ mutant obtained from Prof. D.H.Hall, (Gorgia Institute 
of Technology, Atlanta) was mutagenized by the EMS. After mutagenesis 
the phenotype of some of the frd^ mutants had changed from halo* to halo" 
(Fig. 1). The halo- phenotype is because of the defect in nrclB or cd gene 
that code for a small subunit of ribonucleotide reductase and cytidine 
deaminase respectively. Due to the inactivation of either of the gene syn-
thesis of uracil is blocked and uracil will no more be accumulated in T4 
phage which in turn would not release out of lysed phage particles and 
hence plaques are devoid of halo* phenotype (Fig. 2,3,4). The percent in-
activation and mutational frequency of the EMS-treated frd^^ mutants were 
found to vary with respect to the concentration of EMS. It also varied in the 
presence and absence of sodium thiosulphate which was used to quench 
the reaction (Table 1,2). 
Isolation and purification of mutant plaques: The EMS treated frd^ 
mutants were plated on GPTG plates along with OK305 cells.Screening for 
appearance of halo* phenotype of the plaques was done. Approximately 
800 halo- plaques were picked after EMS mutagenesis. Each plaque was 
suspended in 1 ml of diluting fluid. The titre of all the mutants were checked 
and recorded as 10« to 10' PFU/ml. Appropriate dilutions of the mutant 
phage were then made and plated again on GPTG medium to check the 
purity of the isolated phage mutants. The isolated mutant was considered 
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to be pure if the plating of test mutant on GPTG did not result in the appear-
ance of any halo* plaque out of 10^ plaques screened for this purpose. A 
total of 432 frdlnrdB double (halo*) mutants were thus purified. 
Isolation of nrdB mutants: The frd^ double mutants (hale) obtaned by 
EMS mutagenesis were further screened for the presence of a mutation 
within the nrdB gene (Fig. 5). The basis of selection of nrdB mutation was 
the marker rescue with the pJSSIO clone (Table 3). This clone contained 
the nrdB gene in the plasmid. This screening resulted in the isolation of 
156 out of 432 test mutants within the nrdB gene (Table 4). 
Mapping of nrdB intron mutants: The nrdB gene mutants thus obtained 
were mapped within the nrdB intron using the subclones of the nrdB gene . 
Genetic mapping of nrdB intron mutants were performed on the basis of the 
recombination based marker rescue technique (Fig. 5). A total of 31 muta-
tions were mapped within or near the intron of nrdB gene, (Table 5,6). 
The frequencies of hafo* (wt) phenotype of these mutations with the 
pJBKI (intron) subclone (Fig. 6) were recorded to be significant (Table 5). 
Since each mutation can be placed at its appropriate position within the 
intron on the basis of their frequencies, the lower recombination frequency 
of mutant with wt should always lie towards the end of the sequences 
whereas mutation at the centre would always show higher frequencies (Fig. 
10). Most of the mutations showing lower frequencies were mapped near 
the ends of intron while 31 of the phage showed remarkably high frequen-
cies of halo* and are mapped in the middle of the intron. 
Mapping within JG106 (A+B) region of intron: The strategy for narrow-
ing down the mapping of mutations within the subregions of intron was based 
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on the same principle that a sub-region of intron, cloned within the plasmid 
pJG106 (region;A+B) (Fig. 6) was used to rescue the wt character (halo*) 
(Fig. 2). Seven mutations showed positive marker rescue with the subclone 
pJG106 (Table 7). This strongly suggests that these seven mutations were 
located within the A+B region of the 5' end of nrdB intron (Table 8). 
Mapping within JG108 (C+D) region of intron: All of the 31 mutants were 
checked with pJG108 (Fig. 5,6) subclone for the positive marker rescue 
(Table 9). Out of 31 frd•^n^dB' mutants, 24 mutants showed positive marker 
rescue with the pJGlOB and hence were mapped within C + D region of the 
nrdB intron (Table 10). 
Mapping within sub-regions of JG106 (A+B): The JG106 region (A+B) 
was further subdivided into two regions A and B for which subclone pJBS1 
and pJSR1 were used for mapping by marker rescue (Fig. 5) 
Mapping within JBS1 (A) region of intron: All of these seven mutants 
(Table 8) were checked for marker rescue with the subclone pJBS1 (Fig.5,6), 
All of them were showing positive marker rescue with pJBSI (Table 11) 
suggesting that all of them were carrying mutations within or near the 5' 
end of the region A of nrdB intron (Table 12). 
Mapping within JSR1 (B) region of Intron: The second attempt of marker 
rescuing of all seven mutants, which have already mapped within JBS1 re-
gion, was carried out with the pJSR1 subclone (Fig. 6). None of them exhib-
ited a positive marker rescue with this clone (Table 13) therefore, all of the 
seven mutations could be mapped within the A region of the nrdB intron. 
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on the same principle that a sub-region of intron, cloned within the plasmid 
pJG106 (region;A+B) (Fig. 6) was used to rescue the wt character (halo*) 
(Fig. 2) . Seven mutations showed positive marker rescue with the subclone 
pJG106 (Table 7). This strongly suggests that these seven mutations were 
located within the A+B region of the 5' end of nrdB intron (Table 8). 
Mapping within JG108 (C+D) region of intron: All of the 31 mutants were 
checked with pJG108 (Fig. 5,6) subclone for the positive marker rescue 
(Table 9). Out of 31 frd^^n^dB- mutants, 24 mutants showed positive marker 
rescue with the pJGlOB and hence were mapped within C + D region of the 
nrdB intron (Table 10). 
Mapping within sub-regions of JG106 (A+B): The JG106 region (A+B) 
was further subdivided into two regions A and B for which subclone pJBSI 
and pJSRI were used for mapping by marker rescue (Fig. 5) 
Mapping within JBS1 (A) region of intron: All of these seven mutants 
(Table 8) were checked for marker rescue with the subclone pJBS1 (Fig.5,6), 
All of them were showing positive marker rescue with pJBS1 (Table 11) 
suggesting that all of them were carrying mutations within or near the 5' 
end of the region A of nrdB intron (Table 12). 
Mapping within JSR1 (B) region of intron: The second attempt of marker 
rescuing of all seven mutants, which have already mapped within JBS1 re-
gion, was carried out with the pJSRI subclone (Fig. 6). None of them exhib-
ited a positive marker rescue with this clone (Table 13) therefore, all of the 
seven mutations could be mapped within the A region of the nrdB intron. 
b3 
Mapping within sub-regions of pJG108 (C-t-D): The subclone pJG108, 
having C+D region cloned in it was further subdivided into two regions, C 
and D. 
Mlapping within JSK7 (D) region of intron: The fine structure mapping of 
these twenty four mutants was carried out with pJSK7 (Table 14) and it was 
determined that out of 24 mutants 13 were mapped within JSK7 region (Ta-
ble 15). Since all these thirteen mutants showed positive marker rescue 
with pJSK7, these lie within the 3'end of the D region of the nrdB intron. 
The remaining, eleven (24-13=11) mutants would map within the C re-
gion of nrdB intron by default (Table 16). 
Dot blot hybridization splicing assay : This hybridization assay was per-
formed to analyse the splicing defective point mutations within the nrdB 
intron of bacteriophage T4. End-labelled DNA probes were designed such 
that their bindings were dependent on the splicing of the nrdB intron. Four 
DNA probes were used in this splicing assay (Table 17). Appropriate wild 
type T4 RNA preparation was used to measure splicing proficiency. 
The Exil probe of 22 nucleotides was designed to anneal the nucleotide 
bases from 1865 to 1686 of Exon II region. It was used to ensure the pres-
ence of nrdB mRNA in the preparations. The second probe, ExI-Exll was 
used to bind at the splice junction specifically to the sequence starting from 
1189to1200ofexonland 1799 to 1811 of exon II. The third probe, ExI-IVS 
was designed to bind with the 5'-cutting site at sequence starting from 1189 
to 1211 nucleotide bases of exon I and intron. The fourth probe, IVS-Exll on 
the other hand was designed to bind with the 3'-cutting site at the sequence 
starting from 1788 to 1810 nucleotide bases of intron and exon II. The ExIl 
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probe served as a positive control because it will bind to all spliced and 
unspliced nrdB RNA. None of the RNA preparations displayed negative re-
sponse with this probe (Fig. 7,8,9). Positive binding of the probe ExI-Exll 
would show the excision of intron and ligation of exons. And negative bind-
ing (i.e. no binding) would represent any defect in splicing. Positive bind-
ing of the probe, ExI-IVS would imply the defect at the 5'-cutting site of 
exon I and intron whereas positive binding of IVS-Exll probe would show 
splicing defect at the 3'-cutting site of intron and exon II. 
Dot blot hybridization splicing assay of mutations in the region A of 
the nrdB intron: All the 7 mutants in the region A except AM668 exhibited 
negative binding with the probe ExI-Exll, while the AM668 showed positive 
binding with this probe similar to wild type (Fig. 7). The probe ExI-IVS 
displayed positive binding with all the mutants of this region, while wt ex-
hibited negative binding as shown in fig. 7. The fourth probe, IVS-Exll did 
not show any binding to any of the mutants of this region (Fig. 7). This dot 
blot assay suggests that all the 7 mutants are splicing defective at their 
5'cutting site but AM668 seems to be partially splicing defective at the 5'-
cutting site (Table 18 ). 
Dot blot splicing assay of mutants in region C of the nrdB intron: Out 
of 11 mutants, AMI52 and AM779 showed positive binding with the probe 
ExI-Exll, and the rest exhibited negative binding (Fig. 8). All the mutants of 
the region C showed positive binding with the probe ExI-IVS. The mutants, 
AM11, AM753, AM764 and AM779 displayed positive binding with the probe 
IVS-Exll whereas AM38, AM49, AMI66, AM326, AM429, AMI 52, and AM775 
did not show any binding with this probe (Fig. 8). One mutant, AMI 52 was 
found to be partially defective in splicing at the 5'cutting site whereas AM779 
seems to have partial defect at both the 5' and 3' cutting sites. The mutant 
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AM11, AM753, AM764 would be splicing defective at both the cutting sites, 
and the remaining mutants have a defect at their 5' cutting site (Table 19). 
Dot blot splicing assay of mutants in the D region of the nrdB intron: 
There were 13 mutants in region D, (Table 20) out of these only three mu-
tants, AM442, AM717, and AM730 displayed a positive response with the 
probe, EXI-EXII. The remaining mutants showed negative binding with this 
probe. The probe ExI-IVS resulted in positive binding with the mutants AM112 
and AMI53 (Fig. 9). As far as the probe IVS-EXII was concerned, all the 
mutants except AM153 displayed a positive response with this probe (Fig. 
9). The mutant AM112 was splicing defective at both the 5" and 3' cutting 
sites whereas AMI 53 was found to be defective at its 5'cutting site only. 
Moreover, the mutants AM442, AM717, AM730 seems to have partial de-
fects at the 3'cutting site. The remaining (AM342, AM425, AM445, AM484, 
AM487, AM492, AM719, AM724) were defective at the 3'splice site (Table 
20). 
Measurement of the genetic distances between the nrdB intron muta-
tions: The frequencies of the halo* phenotype recombinants were used to 
calculate the relative genetic distances between mutants that had point mu-
tations mapping within the same marker rescue clone/subclone as shown in 
fig. 6. For every genetic cross, approximately 5000 non-halo plaques were 
screened and the total number of halo* plaques for each mutant showing 
positive marker rescue were used to predict the genetic distance (Fig. 10) 
of that mutation from the end of the clone / subclone and also the relative 
distances of mutants with each other (Table 21,22,23 ). 
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DISCUSSION 
As in the protein enzymes, the folding of the intron results in the for-
mation of an active site juxtaposing key residues that are widely separated 
in primary sequence. This RNA structure catalyses splicing by bringing the 
6' and 3' splice sites and guanosine into close proximity, and by activating 
the phosphodiester bonds at the splice site (Cech, 1990). Different group I 
introns, including the nrdB intron, have relatively little sequence similarity, 
but all share a series of the short conserved sequence elements P,Q,R and 
S with part of P/Q and R/S base pairing in conserved structure (Cech, 1988). 
These conserved elements are known to be important, because they are 
sites of cis-acting splicing mutations. This is not to say that the less or 
non-conserved structure will be functionally irrelevent, they could serve to 
position the catalytic residues or to stabilize the overall structure of the 
intron, or they could provide binding site for proteins that facilitate or regu-
late RNA splicing in vivo (Waring and Davies, 1984; Cech, 1988; Lai and 
Hall, 1997). This sequence complementarity between pairs of elements may 
allow them to interact to form a complex higher order structure. This com-
plex structure appears to be essential for splicing activity. The P and Q 
sequences are closer to the 5' splice site of the intron whereas R and S 
sequences are closer to the 3' splice site of the intron. The region A con-
tains both P and Q sequences whereas region B does not contain any of 
the conserved sequences. About half of the R sequence that is less con-
served than the region A is carried by region C . Region D encompasses 
the remaining half of the R sequence and the whole of S sequence (Lai and 
Hall, 1993). 
In the present study we have mutagenized frdi T4 mutants with 
ethylmethane sulphonate. Previously, several workers have used 
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hydroxylamine and nitrous acid for the mutagenesis of nrdB, frd^ and td 
mutants (Hall et al, 1987; Lai and Hall, 1993; Kwon et al, 1996). 
Hydroxylamine is specific for cytosine and hence it induces unidirectional 
mutagenesis whereas EMS induces bidirectional GC to AT and AT to GC 
transitions. The GC to AT mutagenesis occurs at a remarkably higher rate 
than the AT to GC transition (Freese, 1961). We have isolated 31 EMS 
induced nrdB mutants as compared with 30 hydroxylamine induced mutants 
within the nrdB intron of T4 phage (Lai and Hall, 1993). The present study 
revealed that none of mutations were present within the B region of nrdB 
intron which was outside the conserved P, Q, R, and S sequences and hence 
our data suggest that only the conserved regions of the intron are involved 
in pre-mRNA splicing. 
In our study 7 mutations were mapped in the region A similar to what 
was obtained by Lai and Hall (1993). However, unlike their study, we could 
not obtain any border line mutation in the region B. That mutation obtained 
by Lai and Hall (1993) was probably a border line mutation since It showed 
positive marker rescue with subclones corresponding to regions A as well 
as B, at a frequency of less than 5%. Cutting the Sty\ site for subcloning 
produces staggered ends and thus a mutation in this site would show posi-
tive marker rescue with both subclones at a very low frequency. In addition, 
the region A contains both P and Q conserved sequences and the last base 
of the conserved sequence is the last base of subclone too. Thus there is 
strong possibility that the mutation is in the Sfyl site. None of the mutations 
mapped in the B region as shown by Lai and Hall (1993). Eleven mutations 
mapped in the region C which is supposed to have less conserved sequences 
than that of A. Surprisingly, 3 out of 11 mutants within the region C dis-
played the 3'splice defect by dot blot assay (Table 19). Moreover the re-
markable marker rescue frequencies with pJG108 clone carrying C+D 
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region of these mutants also suggest that the mutations lie within the non-
conserved ORF region of the nrdB intron (Table 9). Lai and Hall (1997) did 
not find any mutation using hydroxylamine within the ORF region. This 
observation is consistent with the idea that the ORF region of nrdB intron 
could also play an important role in the splicing reaction. The absence of 
the conserved region might imply that tertiary interactions between the ORF 
and neighbouring conserved regions probably stabilize the RNA structure 
essential for splicing. Such an idea has also been put forward by previous 
workers in case of other group I introns (Inoue et al, 1985). These muta-
tions within the suspected ORF region would have escaped the screening 
by Lai and Hall (1993) owing to limited target of hydroxylamine compared 
with the EMS targets. The hydroxylamine specifically attacks upon the C 
residues of the DNA thus resulting in GO to AT transition whereas EMS can 
attack upon all the DNA bases with greater or less intensity having more 
preference undoubtedly causing the GC to AT transition and also causing 
reverse transition of AT to GC. This also confirms to the total number of 
mutants within the C region to be 11, contrary to a total of 7 mutations within 
this region reported previously (Lai and Hall, 1993). These additional three 
mutants could have been the result of AT to GC transition. Interestingly the 
remaining 8 mutations in our case have mapped within the same small stretch 
(96 bases) of conserved nucleotides within the C region. Lai and Hall (1993, 
1997) also found mutations within this stretch. The dot blot splicing assay 
and marker rescue frequency data support our contention (Table 19,22 ). 
Region D which contains a roughly equal amount of conserved sequences 
to region A has 13 mutations mapped in it. 
These mapping results suggest that the conserved sequences in the 
nrdB intron, like the Wand other group I introns, are important in pre-mRNA 
sp'icing (Michel et al, 1982; Davies et al, 1982; Cech et al, 1983). 
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Most of the mutations were mapped towards the 3'end of the nrdB intron 
compared to the td intron which has shown 15 mutations within 167 
nucleotides of the 5'end and at least 12 mapped within 219 nucleotides of 
the 3'end of the intron (Hall et al, 1987). The present study also supports 
the findings of others that these are the ends of intron (5' and 3') which 
play a vital role in splicing by folding the secondary structure into a very 
precise tertiary structure configurations involving the complex P9.0 and P10 
pairings (Hall et al, 1987; Lai and Hall, 1993, 1997). 
Like many eukaryotic group I introns, the nrdB intervening sequence 
contains an ORF (Chu et al, 1986). The nrdB intron ORF (294 bases) is 
smaller than the td ORF (778 bases) which is again smaller than nrdD (788 
bases) (Gott et al, 1988; Shub et al, 1988). The ORF sequences of other 
group I introns are not usually highly conserved and are looped out of sec-
ondary structure model for RNA folding (Waring and Davies, 1984). Simi-
larly for the td intron these genetic studies imply that the intron ORF is not 
required for formation of the active splicing conformation (Hall et al, 1987). 
However, our findings reveal that the 3'end of the nrdB intron ORF is es-
sential for splicing. 
Seven mutations were mapped within the A region similar to that of Lai 
and Hall (1993). The sequencing analysis of those mutants clearly sug-
gests the mutation sites of three mutants which were lying within exon I of 
nrdB gene. Interestingly the dot blot assay and MR frequency data favour 
the presence of at least three mutations existing very close to the 5'end of 
the introii in our case also. It is noteworthy that our clone pJBKI for marker 
rescue assay was carrying 80 additional nucleotides of the Exon I. 
70 
Dot-blot splicing assay results suggest that most of the splicing de-
fective mutants showed their defects at either 5' or 3' cutting site. While 
some of them were defective at both the cutting sites. Although some of the 
splicing defective mutants were mapped at the 3' end of intron yet they 
disrupt the 5' splicing activity. For instance mutant AM153 (Table 20) lies 
within the region D of the intron, inspite of that it showed splicing defect at 
5' cutting site. It clearly suggests the folding of secondary structure of intron 
during splicing. 
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Table 1 : Effect of EMS treatment on the infectivity o f ^ l mutants of T4 phage 
under extracellular conditions. 
Concentration of 
mutagenic treatment 
Xofrd\ mnXant of T4 
0.04M EMS 
+ Na,S,0, 
2 2 J 
0.04M EMS 
- Na,Sp3 
0.1 MEMS 
+ Na,S,03 
0.1 MEMS 
- Na,Sp, 
0.2M EMS 
+ Na,S,03 
0.2M EMS 
-Na,SA 
0.4M EMS 
+ Na,SA 
0.4M EMS 
- Na,S,0. 
2 Z J 
No. of 
10-' 
-
-
-
2000 
-
10 
90 
10-^  1 
-
-
3590 
-
170 
1900 
-
13 
plaques 
plate 
10-3 
2000 
-
355 
1040 
-
220 
-
-
on 
\o-* 
175 
565 
220 
~ 
14 
-
-
each 
10-* 
-
4 
-
"" 
-
-
litre 
(PFU/ml) 
1.87xl0^x 10 
1.87xl0« 
4.8 X lO'xlO 
4.8x10' 
3.57 X lO'-x 10 
3.57x10' 
1.62x10^x10 
1.62 X 10" 
1.85xlO'xlO 
1.85 X 10* 
1.83xlO''xlO 
1.83x10' 
1 X lO'x 10 
1x10^ 
1,1 xlO'xlO 
1.1 xlO-' 
% 
Inactivation 
92 
79 
98.43 
93 
99.92 
99.2 
99 999 
99.995 
•Original titre of T4 phage before treatment was 2.27x10''PFU/ml. 
- Sign indicating the absence of plaque. 
The number 10 is dilution factor 
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Table 2 : EMS induced mutagenesis infrdl mutants of bacteriophage T4 under the 
extracellular treatment conditions. 
Concentration of 
mutagenic treatment 
to Jrd\ mutant of T4 
0.04M EMS 
+ Na,S,0, 
2 Z J 
0.04M EMS 
- Na,S,03 
0.1 MEMS 
+ Na,S,0, 
2 2 J 
O.IMEMS 
- Na,S,0. 
2 2 J 
0.2M EMS 
+ Na,Sp3 
0.2M EMS 
-Na^Sp, 
0.4M EMS 
+ Na,Sp3 
0.4M EMS 
- Na,S,0,, 
No. of Mutant plaques (halo" 
plate 
10-' 
-
-
-
-
-
-
-
10-2 
-
-
-
-
-
-
-
-
10-^  
5 
6 
6 
3 
-
-
-
-
) on each 
io-» 
-
-
-
-
7 
6 
-
-
Titre 
(PFU/ml) 
5 x i a » x l O 
5x10^ 
6x lO^x 10 
6 X I0-' 
6x l0^x 10 
6x 10' 
3x 10-^ x 10 
3x10 ' 
7x lO'xlO 
7x10* 
6 x l 0 ' x 10 
6x10* 
-
-
Mutational 
Frequency 
(M.F.)* 
2x10-' 
2x10-* 
2x10-' 
1x10-* 
3x10-^  
2.6x10-^ 
-
-
•Original titre of T4 phage before treatment was 2.27x10'PFU/ml. 
- Sign indicating the absence of plaque. 
The number 10 is dilution factor 
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Table. 3 : Marker rescue mapping of isolated mutants obtained from 
dihydrofolate reductase defective T4 phage with pJSSlO clone 
carrying the whole nrdB gene. 
frd\ nrdB 
double 
mutants 
AM5 
AMll 
AM38 
AM49 
AM54 
AM57 
AM66 
AM80 
AM84 
AM91 
AM92 
AM 100 
AM 104 
MR Mapping with pJSSlO 
No. of halo"^  
plaques 
315 
2500 
3100 
2500 
3000 
4250 
250 
400 
275 
400 
400 
665 
1800 
Vo Frequency of halo"^  
plaques* 
6.3 
50 
62 
50 
60 
85 
5 
8 
5.5 
8 
8 
13.3 
36 
AM106 
AMI 11 
AM112 
AM119 
AM122 
AM124 
AM141 
AM149 
AM152 
AM153 
AM 154 
AM155 
AM 160 
AM 162 
AM 166 
AM168 
AM171 
AM 174 
AM 186 
AM 190 
AM 192 
AM284 
AM288 
AM293 
AM294 
AM297 
AM300 
AM306 
AM310 
AM312 
750 
2500 
3500 
500 
550 
1000 
3500 
750 
4375 
4500 
500 
4750 
500 
350 
4500 
800 
225 
240 
290 
345 
900 
600 
300 
475 
500 
3500 
1250 
4000 
250 
450 
15 
50 
70 
10 
11 
20 
70 
15 
87.; 
90 
10 
95 
10 
7 
90 
16 
4.5 
4.8 
5.8 
6.9 
18 
12 
6 
9.5 
10 
70 
25 
80 
5 
9 
frd\ nrdB 
double 
mutants 
AM326 
AM334 
AM342 
AM345 
AM350 
AM354 
AM358 
AM359 
AM378 
AM382 
AM387 
AM396 
AM397 
A. "fc. * "^  r\c\ 
M R Mapping with pJSSlO 
No. of halo' 
plaques 
2500 
500 
1600 
500 
350 
400 
425 
3000 
150 
300 
450 
600 
250 
% Frequency of halo^ 
plaques * 
SO 
10 
32 
10 
7 
8 
8.5 
60 
6 
9 
12 
5 
AM399 
AM405 
AM408 
AM415 
AM424 
AM425 
AM429 
AM436 
AM437 
AM442 
AM443 
AM445 
AM449 
AM454 
AM473 
AM481 
AM482 
AM484 
AM487 
AM492 
AM496 
AM505 
AM506 
AM510 
AM511 
AM514 
AM532 
AM536 
AM538 
AM550 
AM552 
AM557 
AM559 
4500 
400 
550 
605 
550 
3250 
2500 
750 
530 
2800 
325 
1750 
2000 
350 
590 
550 
780 
2000 
750 
1000 
280 
425 
935 
2550 
375 
440 
530 
405 
475 
435 
455 
550 
330 
90 
8 
11 
12.1 
11 
65 
50 
15 
10.6 
56 
6.5 
35 
40 
7 
U.8 
11 
15.6 
40 
15 
20 
5.6 
8.5 
18.7 
51 
7.5 
8.8 
10.6 
8.1 
9.5 
8.7 
9.1 
n 
6.6 
M R Mapping with pJSSlO 
frd\ nrdB 
double 
mutants 
No. of halo" 
plaques 
1250 
550 
1050 
300 
450 
340 
1875 
550 
1250 
350 
405 
475 
400 
750 
750 
415 
750 
350 
625 
1250 
1000 
455 
750 
2250 
500 
215 
2000 
250 
900 
687 
465 
405 
625 
400 
780 
215 
590 
1300 
800 
2945 
2250 
175 
330 
250 
1200 
2375 
% Frequency of halo 
plaques * 
25 
10 
21 
6 
9 
6.8 
37.5 
11 
25 
7 
8.1 
9.5 
8 
15 
15 
8.3 
15 
7 
12.5 
25 
20 
9.1 
15 
45 
10 
4.3 
40 
5 
18 
13.75 
9.3 
8.1 
12.5 
8 
15.6 
4.3 
11.8 
26 
16 
58.9 
45 
3.5 
6.6 
5 
24 
47.5 
AM560 
AM561 
AM563 
AM567 
AM570 
AM571 
AM581 
AM583 
AM 5 94 
AM596 
AM597 
AM601 
AM603 
AM611 
AM614 
AM616 
AM626 
AM635 
AM636 
AM642 
AM643 
AM647 
AM651 
AM654 
AM662 
AM667 
AM668 
AM673 
AM680 
AM685 
AM693 
AM694 
AM695 
AM703 
AM704 
AM710 
AM713 
AM714 
AM715 
AM717 
AM719 
AM720 
AM721 
AM722 
AM723 
AM724 
frdX nrdB 
double 
mutants 
AM727 
AM730 
AM732 
AM733 
AM735 
AM744 
AM750 
AM753 
AM756 
AM757 
AM759 
AM760 
AM764 
AM765 
AM767 
M R Maping with pJSSlO 
No. of halo^ 
plaques 
1000 
2550 
1500 
200 
155 
275 
1665 
1250 
290 
250 
650 
1500 
2685 
750 
500 
% Frequency of halo" 
plaques * 
20 
51 
30 
4 
3.1 
5.5 
33.3 
25 
5.8 
5 
13 
30 
53.7 
15 
10 
AM769 
AM773 
AM774 
AM775 
AM779 
AM781 
580 
290 
310 
2500 
4150 
1000 
11.6 
5.8 
6.2 
50 
83 
20 
* Total number of plaques screened. 5000 
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Table 4: The nrdB candidate mutants isolated from EMS treated frdl mutants 
phage that exhibited MR^ with pJSSlO clone carrying whole nrdB gene 
AM5 
AM66 
AM 104 
AM124 
AM155 
AM 174 
AM293 
AM312 
AM354 
AM396 
AM424 
AM443 
AM482 
AM506 
AM538 
AM561 
AM583 
AM611 
AM642 
AM667 
AM694 
AM714 
AM722 
AM733 
AM757 
AM769 
156 Candidate mutants that show MR^ 
AMll 
AM80 
AM106 
AM141 
AM160 
AM 186 
AM294 
AM326 
AM358 
AM397 
AM425 
AM445 
AM484 
AM510 
AM550 
AM563 
AM594 
AM614 
AM643 
AM668 
AM695 
AM715 
AM723 
AM735 
AM759 
AM773 
AM38 
AM84 
AMI 11 
AM149 
AM162 
AM 190 
AM297 
AM334 
AM3 59 
AM399 
AM429 
AM449 
AM487 
AM511 
AM552 
AM567 
AM596 
AM616 
AM647 
AM673 
AM703 
AM717 
AM724 
AM744 
AM760 
AM774 
AM49 
AM91 
AM112 
AM 152 
AM 166 
AM 192 
AM300 
AM342 
AM378 
AM405 
AM436 
AM454 
AM492 
AM514 
AM557 
AM570 
AM597 
AM626 
AM651 
AM680 
AM 704 
AM719 
AM727 
AM750 
AM764 
AM775 
with pJSSlO 
AM54 
AM92 
AM119 
AM153 
AM 168 
AM284 
AM306 
AM345 
AM382 
AM408 
AM437 
AM473 
AM496 
AM532 
AM559 
AM571 
AM601 
AM635 
AM654 
AM685 
AM710 
AM720 
AM730 
AM753 
AM765 
AM779 
AM57 
AMIOO 
AM122 
AMI 54 
AM171 
AM288 
AM310 
AM350 
AM387 
AM415 
AM442 
AM481 
AM505 
AM536 
AM560 
AM581 
AM603 
AM636 
AM662 
AM693 
AM713 
AM721 
AM732 
AM756 
AM767 
AM781 
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Table. 5 : Marker rescue mapping of isolated mutants obtained from 
dihydrofolate reductase defective T4 phage with pJBKl clone 
carrying the intron of nrdB gene. 
frdl nrdB 
double 
mutants 
M R Mapping with pJBKl 
No. of halo"^  
plaques 
% Frequency of halo' 
plaques * 
AMll 
AM38 
AM49 
AM54 
AM57 
AMl l l 
AM112 
AM141 
AMI 52 
AM153 
AM166 
AM326 
AM342 
AM359 
AM399 
AM425 
AM429 
AM442 
AM445 
AM484 
AM487 
AM492 
AM668 
AM717 
AM719 
AM724 
AM730 
AM753 
AM764 
AM775 
AM779 
50 
60 
49 
4 
5 
10 
6 
10 
70 
10 
40 
40 
5 
10 
9 
11 
84 
12 
10 
11 
10 
12 
6 
5 
11 
6 
10 
49 
63 
57 
55 
• Total number of plaques screened. 5000 
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Table 6: The nrdB candidate mutants isolated from EMS treated,^! mutant phage 
exhibited MR^with pJBKl subclone carrying intron of nrdB gene. 
31 Candidate mutants that show MR^ with pJBKl 
AMll 
AM57 
AM 152 
AM342 
AM429 
AM487 
AM719 
AM 764 
AM38 
AMlll 
AM 153 
AM359 
AM442 
AM492 
AM 724 
AM775 
AM 49 
AM112 
AM 166 
AM399 
AM445 
AM668 
AM730 
AM 779 
AM 54 
AM141 
AM326 
AM425 
AM484 
AM717 
AM753 
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Table 7: Marker rescue mapping of the isolated intron mutants with pJG106 
clone carrying A+B region of the intron 
frd\ nrdB 
double 
mutants 
AMU 
AM38 
AM49 
AM54 
AM57 
AMll l 
AM112 
M R Mapping with pJG106 
No. of halo^ 
plaques 
None 
None 
None 
200 
300 
1250 
None 
% Frequency of halo* 
plaques * 
-
-
-
4 
6 
25 
-
AM141 
AMI 52 
AMI 53 
AM166 
AM326 
AM342 
AM359 
AM399 
AM425 
AM429 
AM442 
AM445 
AM484 
AM487 
AM492 
AM668 
AM717 
AM719 
AM724 
AM730 
AM753 
AM764 
AM775 
AM779 
1750 
None 
None 
None 
None 
None 
1500 
1000 
None 
None 
None 
None 
None 
None 
None 
750 
None 
None 
None 
None 
None 
None 
None 
None 
30 
20 
15 
* Total number of plaques screened 5000 '••'. l - s , 
_^ 
.^!,^ , 
-r-6'^Sl/ 
- - . - . _ 3» 
Table 8 : The nrdB candidate mutants isolated from EMS treated frdl mutant phage 
exhibited MR^with pJG106 clone carrying (A+B) region of intron. 
7 Candidate mutants that show MR^with pJG106 
AM54 AM57 AMI 11 
AM141 AM359 AM399 
AM668 
79 
Table 9: Marker rescue mapping of the isolated intron mutants with pJGlOS 
clone carrying C+D region of the intron. 
frd\ nrdB 
double 
mutants 
M R Mapping with pJGlOS 
% Frequency of halo* 
plaques * 
AMll 
AM38 
AM49 
AM54 
AM57 
AMll l 
AM 112 
AM141 
AM152 
AM153 
AMI 66 
AM326 
AM342 
AM359 
AM399 
AM425 
AM429 
AM442 
AM445 
AM484 
AM487 
AM492 
AM668 
AM717 
AM719 
AM724 
AM 730 
AM753 
AM 764 
AM 775 
AM779 
50 
50 
35 
15 
90 
15 
25 
25 
10 
25 
80 
20 
20 
25 
18 
25 
9 
20 
12 
20 
50 
75 
45 
45 
* Total number of plaques screened 5000 
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Table 10: The nrdB candidate mutants isolated from tiie EMS treated frd\ 
mutant phage exhibited positive MR with pJGlOS clone carrying 
C+D region of intron. 
AMll 
AM 152 
AM342 
AM445 
AM717 
AM753 
24 Candidate 
AM38 
AMI 53 
AM425 
AM484 
AM719 
AM764 
mutants that show MR^ 
AM49 
AM 166 
AM429 
AM487 
AM724 
AM775 
with pJGlOS. 
AM112 
AM326 
AM442 
AM492 
AM730 
AM779 
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Table 11: Marker rescue mapping of the isolated intron mutants with pJBSl 
clone carrying region A of the intron. 
frd\ nrdB 
double 
mutants 
M R Mapping with pJBSl 
No. of halo* 
plaques 
% Frequency of halo^ 
plaques * 
AM54 
AM57 
AMI 11 
AM141 
AM359 
AM399 
AM668 
5 
8.3 
12 
15 
6 
10 
9 
• Total number of plaques screened 5000 
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Table 12: The nrdB candidate mutants isolated from EMS treated frdl mutant 
phage that exhibited positive marker rescue with pJBSl clone 
carrying the region A of intron. 
7 Candidate mutants that show MR^ with pJBSl 
AM54 
AM141 
AM668 
AM57 
AM359 
AMl l l 
AM399 
Total number of plaques screened. 5000 
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Table 13: Marker rescue mapping of the isolatd intron mutants with pJSRl 
clone carrying region B of the intron. 
frd\ nrdB 
double 
mutants 
AM54 
AM 5 7 
AMI 11 
AM141 
AM359 
AM399 
AM668 
M R Mapping with pJ^Rl 
No. of halo 
plaques 
None 
None 
None 
None 
None 
None 
None 
% Frequency of halo" 
plaques * 
-
* Total number of plaques screened. 5()()() 
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Table 14: Marker rescue mapping of the isolated intron mutants with pJSK7 
clone carrying the region D of the intron. 
frd\ nrdB 
double 
mutants 
AMll 
AM38 
AM49 
AM112 
AM152 
AM153 
AM 166 
AM326 
AM342 
AM425 
AM429 
AM442 
M R Mapping 
1 
No. of halo' 
plaques 
None 
None 
None 
900 
None 
1000 
None 
None 
900 
500 
None 
250 
with pJSK7 
% Frequency of halo* 
plaques * 
• 
-
-
18 
-
20 
-
-
18 
10 
-
5 
AM445 
AM484 
AM487 
AM492 
AM717 
AM719 
AM724 
AM730 
AM753 
AM764 
AM775 
AM779 
250 
750 
1250 
550 
250 
1000 
200 
250 
None 
None 
None 
None 
5 
15 
25 
11 
5 
20 
4 
5 
* Total number of plaques screened 5000 
85 
Table 15: The candidate mutants isolated from the EMS treated frd\ mutant 
phage that exhibited positive marker rescue with the pJSK7 clone 
carrying region D of intr<»* 
13 Candidate mutants that 
AM153 
AM445 
AM492 
AM717 
AM730 
AM342 
AM484 
AM112 
AM719 
show MR+ with pJSK7 
AM442 
AM487 
AM425 
AM724 
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Table 16: The candidate mutants isolated form the EMS treated/r</l mutant phage 
that are mapped in the C region by default. 
11 Candidate 
AMll 
AM152 
AM429 
AM775 
mutants that are mapped by default 
AM38 
AM166 
AM753 
AM779 
within C region 
AM49 
AM326 
AM764 
57 
Table 17: Description of Oligonucleotides. 
Probes nt' Specificity Sequence (5-3)'' Complement of" 
ExII 22 Exonll CACGTG ATG AACAGC TTC ACCT 1865-1886 
ExI-ExII 25 Splice Junctioft TATCTT TTG CGT. GTACCTTTAACTT 1189-1200.1799-1811 
ExI-IVS 23 Exonl-Intron TArCTTTTGCGT.AAAATGCGCCT 1189-1211 
IVS-ExII 23 Intron-Exonll TCGAA CATACG. GTA CCT TTAACT 1788-1810 
"nt = Number of nuckotides in oligomer. 
''Dots represent sequence junction. 
"The numbering of nucleotides complementary to oligomer is given (mmiberingas Sjoberg B.-M. et al, 
1986) 
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Table 18: Dot blot splicing assay of the mutants mapped within the region A of the 
intron of nrdB gene. 
RNA preparation 
of mutants 
wt 
AM54 
AM57 
AM668 
AMlll 
AM141 
AM399 
AM359 
Exir 
++ 
-H-
-H-
++ 
++ 
++ 
++ 
ExI-ExII 
-H-
++ 
ExI-IVS 
-H-f 
-H-+ 
-H-+ 
-H-
+ 
+ 
+ 
IVS-ExII 
-
Splicing defect 
site 
5' 
5' 
PD(5') 
5' 
5' 
5' 
5' 
Hybridization signal: Undetectable. - . Weak. + : Moderate. 
Partial Splicing defect. PD. 
Intense. 
89 
Table 19: Dot blot splicing assay of the mutants mapped within the region C of the 
intron of nrdB gene. 
RNA preparation 
of mutants 
wt 
AMU 
AM38 
AM49 
AM166 
AM326 
AM429 
AM753 
AM764 
AM152 
AM775 
AM779 
ExII 
-H-
++ 
++ 
++ 
-H-
++ 
-H-
-H-
++ 
-H-
++ 
\ ^^ 
ExI - ExII 
++ 
-
-
-
-
-
-
-
-
+++ 
-
-H-
Exi-rvs 
+ 
+ 
+ 
++ 
++ 
+++ 
+++ 
+++ 
++ 
+++ 
-Hr 
IVS-ExII 
++ 
-
-
-
-
-
+++ 
+++ 
-
-
\ +++ 
Splicing defect 
site 
5 '&3' 
5' 
5' 
5' 
5' 
5' 
5 '&3' 
5'&3' 
PD(5') 
5' 
PD(5' & 3') 
Hybridization signal; Undetectable. -: Weak. + : Moderate. 
Partial Splicing defect. PD 
. Intense. 
so 
Table 20: Dot blot splicing assay of the mutants mapped within the region D of the 
intron of nrdB gene. 
RNA preparation 
of mutants 
ExII ExI - ExII ExI-IVS IVS-ExII Splicing defect 
site 
wt 
AM112 
AM153 
AM342 
AM425 
AM442 
AM445 
AM484 
AM487 
AM492 
AM717 
AM719 
AM724 
AM730 
+++ 
-H-
+++ 
+++ 
5'&3' 
5' 
3' 
3' 
PD(3') 
3' 
3' 
3' 
3' 
PD(3') 
3' 
3' 
PD(3') 
Hybridization signal: Undetectable. - . Weak. + : Moderate. 
Partial Splicing defect. PD 
Intense. 
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Table 21 : Mutants of region A showing recombination frequency with various clones of 
nrdB intron. 
Jrdl nrdB 
double mutants 
AM54 
AM57 
AM668 
AM399 
AM359 
AMIU 
AM141 
% frequencies of halo' plaques with* 
pJBKl 
4 
5 
6 
9 
10 
10 
10 
pJG106 
4 
6 
15 
20 
30 
25 
35 
pJBSl 
5 
8 
9 
10 
6 
12 
15 
*Total number of plaques screened, 5000 
B2 
Table 22: Mutants of region C showing the recombination frequency with various 
clones oinrdB intron. 
% frequencies of halo^ plaques with" 
frd\ nrdB 
double mutants pJBKl pJGlOS 
AM166 
AM326 
AM49 
AM753 
AMU 
AM779 
AM775 
AM38 
AM764 
AM152 
AM429 
40 
40 
49 
49 
50 
55 
57 
60 
63 
70 
84 
25 
25 
35 
50 
50 
45 
45 
50 
75 
90 
80 
"Total number of plaques screened, 5000 
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Table 23: Mutants of region D showing the recombination frequency with various 
clones oinrdB intron. 
frd\ nrdB 
double mutants 
AM342 
AM717 
AM112 
AM724 
AM153 
AM730 
AM445 
AM487 
AM719 
AM425 
AM492 
AM484 
AM442 
% frequencies of halo* plaques with* 
pJBKl 
5 
5 
6 
6 
10 
10 
10 
10 
11 
11 
12 
11 
12 
pJGlOS 
10 
9 
15 
12 
15 
20 
20 
18 
20 
25 
25 
25 
20 
pJSK7 
18 
5 
18 
4 
20 
5 
5 
25 
20 
10 
11 
15 
5 
*Total number of plaques screened, 5000 
Figure 1 : EMS mutagenesis in frd1 mutants of bactenophage T4. 
frd-
infect E.coli OK305 
dUMP accumulation halo*^  phenotype 
EMS mutagenesis 
Jrd-nrdB-\ infect £. co//0K305. halo'phenotype 
i30 
Figure 2: Plaques showing halo* and halo- phenotypes. 

n 
Figure 5: Strategy for the isolation and mapping of the nrdB intron mutants 
into various intron regions by marker rescue exploiting the white halo plaque 
phenotype. 
Halo* character was assigned to these phage clones which formed at least 
5% of the total plaques to be halo* otherwise the clone was considered as 
halo-. 
de novo OK^ os ^ u j ^ .>UDP Zt^dUDP -^^UMP.T—>dTMP —>dTDP 
synthesis 
c-
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UTP dUTF^ 
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Figure 4 : The pyrimidine nucleotide synthesis pathway. Solid lines 
represent bacterial {E.coli) enzymes. Dashed lines represent 
phage induced enzymes for which gene number or abbreviation 
is given, dHMP, dHDP, dHTP = hydroxymethyl cytidine nucleotide; 
FH;, = dihydrofolate. FH4 = tetrahydrofolate. 
T4 Mutant 
Infection 
Defect: dTMP synthase (td) or 
dihydrofolate reductase (frd) 
E. coli OK305 
dUMP 
accumulation 
& leakage 
Defect: de novo pyrimidine biosynthesis 
and cytidine-deoxycytidine deaminase 
Nj/ 
White Halo due to more 
cell growth around plaques 
Figure 3 : The white halo plaque phenotype of bacteriophage T4. 
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Figure 6: A schematic diagram of the nrdB intron clones, pJBK1, complete 
intron carrying subclone (regions A + B + C + D) ; pJG106 (regions A + B), 
pJG108 (regions C + D), pJBSI (region A), pJSR1 (region B), pJSK7 (re-
gion D) and region C divides the sequence covered by pJBKI into smaller 
regions. Bgl II, Sty I, Eco R1, Spc I and Kpn I are the different restriction 
enzymes used for cloning and approximate locations are marked. Number 
in paranthesis indicates the number of mutation within that region. 
Bgl Sty EcoR Spe 
11 
Kpn 
1 ? ? ? ? ^ ORF Exon II 
INTRON-
I 681bp (31) 
T 
4A2bp(7 ) 
!l58bp(7]) 
284bp (0) 
B 
(11) 
C 
239bp(24) 
U3bp(13) 
pJBKI 
pJGlOe 
pJBSI 
pJSRI 
pJGlOe 
pJSK7 
100 
Figure 7: Dot blot splicing assay for the nrdB intron mutants of region A of 
the nrdB intron. 
Probes, Exil, EXI-Exll, ExI-IVS, IVS-Exll correspond to Exon II, Splice junc-
tion, Exon l-lntron (5'cutting), and Intron-Exon II (3' cutting) oligonucleotides 
respectively. 
RNAof 
frd\ nrJB 
mutants 
Probes 
ExII ExI-ExII ExI-IVS IVS-ExII 
wtT4 
AM54 
AM57 
AM668 
AM111 
AM141 • 
AM399 J ^ 
AM359 
I 
1 0 1 
Figure 8: Dot blot splicing assay for the nrdB intron mutants of region C of 
the nrdB intron. 
Probes, Exil, EXI-Exll, ExI-iVS, IVS-Exll correspond to Exon 11, Splice junc-
tion, Exon l-lntron (5'cuttjng), and Intron-Exon II (3' cutting) oligonucleotides 
respectively. 
RNAof 
frd\ nrJH 
mutants 
Probes 
ExII ExI-ExH ExMVS IVS-ExlI 
wtT4 
AM11 
AM38 
AM49 
AMI 66 
AM326 
AM429 
AM753 
AM764 
AM152 
AM775 
AM779 
•I • 
1U2 
Figure 9: Dot blot splicing assay for the nrdB intron mutants of region D of 
the nrdB intron. 
Probes, Exil, EXI-Exll, ExI-IVS, IVS-Exll correspond to Exon 11, Splice junc-
tion, Exon 1-lntron (5'cutting), and Intron-Exon II (3' cutting) oligonucleotides 
respectively. 
RNAof 
frd\ nrJH 
mutants 
Probes 
ExII ExI-ExII ExI-IVS IVS-ExlI 
wtT4 
AM112 
AM 153 
AM342 
AM425 
AM442 
AM445 
AM484 
AM487 
AM492 
AM717 
AM719 
AM724 
AM730 
• • • a 
4 
4 
r 
V • • il 
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Figure 10: A schematic view of the mechanism of marker rescue and its 
application in the prediction of genetic distances. The numbers 1, 2, and 3 
within the rhombus show three different single point mutations within the 
nrdB intron for three independently isolated mutants. The plasmid contains 
the wt sequence for the nrdB clone being used for rescuing either one of 
the 1, 2, or 3 mutations (rhombus) within the nrdB intron of the T4 DNA. 
Depending upon the frequency of crossover, which is in direct relationship 
with the distance from the extremities of the wt insert, relative distance of 
that mutation can be estimated. Thus the mutation 3 will show a high de-
gree of wt recombinants resulting in a high halo* frequency (diagonally 
shaded box), mutation 2 will show a medium degree (vertically shaded 
box) and mutation 1 will show frequency of halo* phenotype (horizontally 
shaded box). 
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INTRODUCTION 
It is known that the folded structure of group I intron is essential for Its 
catalytic activity, as the three dimensional structure of a protein enzyme is 
Important to its biological functions (Waring and Davies, 1984). Several 
approaches have been employed to reveal the important structural features 
for catalytic activity in group I introns. Comparative sequence analysis 
among group I introns of diverse organisms revealed highly conserved pri-
mary sequence elements, conserved secondary structure, and a predicted 
three-dimentional structure (Davies et al, 1982; Burke, 1988; Michel and 
Westhof, 1990). Site directed mutagenesis of the Tetrahymena rRNA gene 
and in vitro splicing reactions utilizing artificial substrates revealed the splic-
ing mechanism and specific structural elements important for self splicing 
of the ribozyme of Tetrahymena (Cech, 1990; Pyle et al, 1990; Pyle and 
Cech, 1991). Basic features of the predicted three dimensional structure 
have beer, elucidated by mutants analysis in vitro and by the use of specifi-
cally positioned photochemical cross linking and affinity cleavage reagents 
(Burke et al, 1990; Wang and Cech, 1992; Wang et al, 1993). 
All the T4 introns {td, nrdB, nrdD) are capable of self-splicing and 
contain the conserved structural features folded into a common secondary 
structure of group I introns ( Waring and Davies, 1984; Shub et al, 1988; 
Belfort, 1990). The td intron is the best characterized and has contributed a 
great deal of information to the understanding of important structural fea-
tures of the group I introns (Hall et al, 1987; Heuer et al, 1991). To examine 
the predicted secondary and tertiary structure of group I introns of T4 phage, 
random mutagenesis utilizing novel technique is very useful. The advan-
tage of this approach is based on phenotypic screening methods (Lai and 
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Hall, 1993, 1997) and easy mapping of mutations due to the promiscuous 
recombination system of T4 (Broker and Doermann, 1975). 
Single base changes in predicted RNA pairing regions which disrupt 
splicing, provide proof that a nucleotide is essential for the splicing reac-
tion. Genetic verification for the involvement of a base pair can be demon-
strated by the isolation of a pseudorevertants that harbours a compensa-
tory mutation at the nucleotide predicted to base pair with the original mu-
tant nucleotide. The double mutants would be predicted to regenerate a 
Watson-Crick base pair in an essential RNA helix, thus permitting intron 
RNA to fold and resulting in the restoration of some degree of autocatalytic 
splicing. Such experiments have been carried out using site specific 
mutagenesis to verify the existence of group I intron RNA pairing regions in 
Tetrahymena (Burke, 1988; Flor et al, 1989; Williamson et al, 1989; Cou-
ture et al, 1990) and yeast mitochondria (Weiss-Brummer et al, 1983; Holl 
etal, 1985). 
In the previous chapter, we have described the isolation of 156 EMS 
induced nrdB mutants. Thirty one of them contained mutations which map 
in or near the nrdB intron. The isolation of second site revertants, which 
restore splicing activity of the nrdB intron mutants by introducing comple-
mentary mutations at second site, might significantly contribute to the un-
derstanding of secondary and tertiary interactions in the splicing process 
in vivo. 
This chapter deals with the study of such revertants to gain an insight 
into the underlying process of autocleavage of pre-nrdB mRNA as well as 
the critical sites required for acquiring the biologically functional structure. 
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METHODS 
EMS mutagenesis of frd^nrdB double mutants of phage T4 particles 
was performed (Fig.1) as described in chapter il. 
After the EMS mutagenesis of frdlnrdB double mutants, we screesled 
the phenotypic revertants for nrdB* marker, based on the halo phenotype. 
Here the revertants (i.e. nrdB*frdV) would change their phenotype from 
halo" to halo* in the pyrimidine limited GPTG medium. 
All the revertants were subjected to marker rescue mapping with the 
clones of nrdB gene and intron as well as subclones of various intronic 
regions, as described in the section of general materials and methods. 
The RNA preparations of the revertants were made as described by 
Lai and Hall (1997) and were U.V. cross linked on to the Hybond nylon 
membrane. The DNA probes, as described in chapter III were used for dot 
blot hybridization assay (Belfort et al, 1985). 
RESULTS 
Isolation of second site revertants: Thirty one frd'\nrdB double mutants 
as described in chapter III were subjected to EMS mutagenesis to obtain 
phenotypic revertants of nrdB intron mutants. The probability of getting true 
reversion is remote but the phenotypic reversion brought about by the sup-
pressor mutation stands a significant chance. These second site or 
pseudorevertants could again be screened by means of the halo phenotype 
(Fig. 2). Reversion in the halo phenotype would occur presumably because 
of the acquisition of the normal biological activity of nrdB gene product. 
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This sort of normal biological activity would result because of the normal 
splicing of the nrdB intron and thus to give rise the normal coding template 
for the translation process. The role of typical secondary and tertiary struc-
ture for the self splicing of introns is well established. Moreover the proc-
ess of conserved region in the group I introns for the splicing function has 
also been well documented. Our mutants mapped within the nrdB intronic 
region, would obviously be carrying mutation in the critical regions. The 
acquisition of the desired conformation would require either the change of 
the mutant base to the normal one or else the parent mutant site being 
unaltered the change might also take place at another site within the intron 
itself so that the conformation is compatible to splicing. 
The mutants located within the region A of intron were subjected to 
undergo the second attempt of mutagenesis and was found that 6 frc/1 nrdB 
mutants showed their revertants. In the region C, 8 mutants displayed 
revertants and there were 9 mutants in the region D that exhibited the 
revertants (Table 1). 
Mapping of revertants of frd^nrdB intron mutants with the pJSSIO 
clone: All the 23 revertants (Table 2) were subjected to the marKer rescue 
mapping with the clone of nrdB gene (pJSS10) (Fig. 2). It was found that ail 
the revertants of the frd^nrdB mutants showed positive marker rescue with 
this clone except AM49R which was not mapped within the nrdB gene (Ta-
ble 3). This data indicates that AM49R was an extragenic revertant while 
the remaining revertants were intragenic (Table 4). 
Mapping of revertants of frdAnrdB intron mutants with the pJBK1 clone: 
These 22 intragenic revertants were then subjected to marker rescue with 
pJBK1 clone carrying the intronic region of nrdB gene (Fig. 2). Four 
lus 
revertants could exhibit the marker rescue with the clone indicating that the 
second mutational site must have been present in the intronic region 
(Table 5,6). 
Finer mapping of revertants with the sub-clones of intron: The finer 
mapping of these four revertants (AM111R, AM429R, AM487R and AM724R) 
was performed with the various subclones of the intron.Only the AM111R 
displayed a positive marker rescue with the pJG106 clone carrying the 
region A+B of the intron. The remaining three revertants exhibited negative 
response, indicating that these revertants could not be mapped in A+B re-
gion (Table 7). Another set of marker rescue mapping was performed with 
the subclone pJBS1 for mapping the AM111R. It was confirmed, that this 
revertant must lie within the region A of intron (Table 8). 
All the four revertants were subjected to marker rescue mapping with 
pJG108 also, and AM429R, AM487R, AM724R were found to be mapped in 
C+D region (Table 9). 
An interesting result was observed with AM429R, whose primary mu-
tation was mapped within the region C (Table 9) but on marker rescue map-
ping with pJSK7, the clone carrying D region of nrdB intron, showed posi-
tive response with this clone and hence the site of reversion must be present 
within the region D. 
The other two revertants (AM724R, AM487R) which were carrying the 
primary mutation within D region could also mapped within the same sub-
region (Table 10). 
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Thus it is clear from our data that the four intronic mutations could be 
suppressed by the reversion within the intronic region itself which was 
quite clear from the suppression within the C region by the one having the 
second mutation in the D region. 
Dot blot hybridization splicing assay: The hybridization of revertants was 
performed similarly as discussed in the chapter III. In this dot blot assay, 
synthetic oligonucleotide probes, designed in such a way that their binding 
to the complementary regions on the RNA is dependent on the presence of 
the spliced or unspliced nrdB RNA, were used as probes (as discribed in 
chapter III). The control probe Exil, binding to both premessage and ligated 
message, gave a signal of the same intensity with wild type. The probe Exl-
Exll, was directed against the ligated splice junction. The probe ExI-IVS, 
was specific to the 5' pre-mRNA splice sites while probe IVS-Exll , specifi-
cally bind to the 3' pre-mRNA splice site. The EXIl probe served as a posi-
tive control because it would bind to all spliced and unsplicod nrdB RNA. 
None of the RNA preparations exhibited negative response with this probe 
(Fig. 3,4,5). 
Dot blot splicing assay of the revertants of f^d^nrdB mutants of the 
region A of nrdB intron: None of the revertants displayed positive bind-
ing with the probe ExI-Exll. It showed the splicing defective nature of all the 
revertants of this region. The probe ExI-IVS, bound to the revertants AM54R, 
AM57R, AM111R and AM141R whereas the revertants AM399R and AM359R 
did not show positive binding to this probe. The revertants AM399R and 
AM359R exhibited binding to the probe IVS-Exll and rest of the revertants 
did not show any binding to this probe (Fig. 3). This data revealed that 
revertants AM54R, AM57R, AM111R and AM141R have defect at their 5'cut-
ting site whereas AM399R and AM359R have defect at their 3'cutting site 
no 
(Table 11). 
Dot blot splicing assay of the revertants of frd^n^dB mutants of the 
region C of nrdB intron: None of the revertants except AM753R dis-
played any significant binding with the probe ExI-Exll. The probe ExI-IVS 
showed positive binding to AM49R whereas others displayed negative bind-
ing to this probe. The revertant AM49R did not show binding to the probe 
IVS-Exll whereas remaining revertants of this region exhibited positive bind-
ing to this probe (Fig. 4). This data implicated that revertant AM49R is de-
fective at its 5'cutting site. But AM753R seems to be partial splicing defec-
tive at its 3' cutting site. The remaining revertants displayed the defects at 
3'cutting site (Table 11). 
Dot blot splicing assay of the revertants of Ird^nrdB mutants of the 
region D of nrdB intron: Out of 9 revertants none of them exhibited posi-
tive binding with the probe ExI-Exll indicating the splicing defective point 
mutations (Fig. 5). The revertants, AM442R, AM445R, AM492R, and 
AM719R, showed positive binding to ExI-IVS and did not show binding to 
the revertants, AM112R, AM342R, AM487R, AM724R, and AM730R. The 
probe IVS-Exll bound to all of the revertants of this region except AM442R 
and AM719R which did not show any binding to this probe (Fig. 5). The 
revertants AM445R and AM492R showed the defect at both 5'«nd 3' cutting 
sites whereas AM442R and AM719R displayed the defect at 5'cuttig site. 
The remaining revertants exhibited the defects at their 3'cutting site (Table 
11). 
I l l 
DISCUSSION 
The ability of group I introns to catalyze their own splicing is mainly 
due to the precise folded structure. The folding of the intron RNA results in 
placing substrate site and catalytic site which are widely separated in the 
primary sequence in close proximity and activating phosphodiester bonds 
at splice sites (Waring and Davies, 1984). The catalytically important sec-
ondary and tertiary structures of group I introns have been s adied with 
several approaches as described in the review of literature (Michel and 
Westhof, 1990). All the group I introns contain several conserved sequence 
elements, P, Q, R, S, which exhibit pair-wise complementarity. This sequence 
complementarity causes all group I introns to fold into strikingly similar struc-
tures involving specific pairing between the conserved sequences, P4, P6 
and P7. This central core was proposed to bring the ends of the intron into 
close proximity, but deletion studies showed that some conserved paired 
regions can be deleted without affecting catalytic activity (Mattson et al, 
1977). Some unpaired sequences between paired regions were also fairly 
conserved in primary sequences. It is thought that the paired regions do 
have a structural role to form secondary structure and the junction sequences 
have a functional role to catalyse self-splicing reactions. One way to un-
derstand the functional relevance of each sequence in paired and unpaired 
regions is to isolate splicing defective nrdB intron mutants (Lai and Hall, 
1993) and their second site revertants which would have a compensatory 
mutation, thus restoring the splicing activity. Characterization of compen-
satory mutations involving sequencing and splicing assay was expected to 
give more comprehensive understanding of secondary and tertiary interac-
tions for nrdB intron catalytic activity (Kwon et al, 1995; Lai and Hall, 1997). 
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We have, therefore, isolated 23 second site revertants of frd^n^dB intron 
mutations (Table 1). Some of the mutants, (AM11, AM153, AM425, AM484, 
AM666, AM717, AM764, and AM779) did not give any revertant. This could 
be explained on the basis of interactions involving other than regular 
Watson-Crick base pairs to form catalytically active structure, and there-
fore primary change would not be compensated by a second mutation in 
one of the interacting base (Kwon et al, 1995). Out of 23 revertants mapped 
within nrdB gene, only one revertant (AM45R) was found to be extragenic 
while the remaining 22 were all intragenic. 
All the revertants were subjected to marker rescue mapping with pJBK1. 
This mapping resulted in the positive marker rescue with 4 out of 22 test 
revertants suggesting, that only a few compensatory mutations would lie 
within the intronic regions. Most of the frd^nrdB intragenic revertants were 
not mapped within the intron probably because these mutants might be 
present on either extreme ends of intron or a little bit toward the end of the 
exon I or start of exon II. Whereas the extragenic mutant that lies outside 
the nrdB gene, would probably disrupt the metabolic pathway of halo phe-
notype. 
The extragenic mutation is very interesting since it could show the 
involvement of other gene product in folding the secondary structure to 
form a peculiar tertiary structure crucial for the splicing activity, or else me 
typical folding of the polycistronic RNA transcript containing the mutations 
in the nrdB and neighbouring genes. 
Although several pre-mRNA containing group I introns are self splic-
ing in vitro, there is compelling evidence that splicing in vivo requires pro-
teins. In the case of yeast mitochondrial RNA splicing, these proteins have 
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been shown to include maturases encoded by ORF of its own intron (Garriga 
and Lambowitz, 1986). 
Several trans-acting mutations have been identified, which block splic-
ing of group I introns. Even though T4 introns are self splicing in vitro, the 
rate of splicing is significantly lower than that in vivo. In the case of td RNA, 
a non-physiologically high temperature (60°) is required to derive the self 
splicing reaction efficiently in vitro, compared to in vivo splicing at 37° or in 
the presence of an E.coli protein, synthesizing S-30 fraction, which sug-
gests the participation of host and / or phage protein (s) (Belfort et al, 
1986). Also the Neurospora CYT-18 protein, a tyrosyl tRNA synthetase, 
which functions in splicing group I introns in mitochondria, was reported to 
promote in vitro splicing of mutants of the distantly related bacteriophage 
T4 td intron (Mohr et al, 1992). According to this model, the enhancement 
of group I intron splicing by various protein factors, is brought about by 
their binding with the RNA to attain a typical conformation necessarily re-
quired for splicing. With this in mind, one of the goals of this study was to 
isolate extragenic revertants, restoring the splicing of defective frd^nrdB 
double mutants. 
Dot blot splicing assay of our revertant AM49R suggested that the 
splicing proficiency of extragenic revertant was not restored. The unique 
characteristic of this revertant could be explained as follows. Since any 
mutation within the frdltd gene besides the defective nrdB gene would re-
sult in accumulation of dUMP, producing weak halos by compensating for 
the effect of leaky nrdB mutation. Thus AM49R would be an extragenic 
revertant, that could not affect the splicing of nrdB RNA, but affected the 
halo phenotype of the mutant, AM49. These results suggest that protein 
factors involved in the splicing of nrdB intron, may not be encoded by the 
1 1 4 . 
genome of T4 phage and hence these proteins must be encoded by its host 
chromosome. 
Our dot blot results on the alteration in the splice site defect in the 
revertant from one cutting site to another are indicative of disruption of the 
secondary structure of intron (Table 11). In other words, the orientation of 
defect had changed because of the disruption of the best conformation of 
intron. For instance, AM399 has a defect at its 5'cutting site but after the 
second mutation in AM399, its revertant AM399R bears the defect at its 3' 
cutting site. Another mutant AM753 is splicing defective at both 5' and 3' 
(Table 19; chapter III) cutting site but its revertant AM753R has the defect 
at its 3'cutting site. This data suggest that the revertant, AM753R is restor-
ing the splicing activity of primary mutant, AM753. Since primary mutant 
was completly splicing defective (Table 19; chapter III) whereas its revertant 
showed partial defect (Table 11; chapter IV) and hence we could suggest 
that the splicing proficiency of this extra-intronic, intragenic revertant has 
been restored to some extant. 
Moreover, the mutant AM445 is defective at its 3'cutting site but Its 
revertant AM445R has the defect at both the sites, i.e. 5' as well as 3' 
cutting sitesThe mutant AM719 is also 3' splice site defective whereas its 
revertant AM719R has a defect at its 5'cutting site only (Table 11). These 
results, therefore, suggest that the cleavage of the intron involves precisely 
defined secondary structure acquiring a complicated tertiary structure which 
is vital for the splicing of group I type introns. Similar explaination was also 
given earlier (Lai and Hall, 1997). 
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Table 1 : Isolation of revertants from thefrdl nrdB double intron mutants of nrdB gene. 
Primary 
Mutants 
AM54 
AM57 
AM668 
AM399 
AM359 
AMin 
AM141 
AM166 
AM326 
AM49 
AM753 
AMll 
AM779 
AM775 
AM38 
AM764 
AM152 
AM429 
AM342 
AM717 
AM112 
AM724 
AM153 
AM730 
AM445 
AM487 
AM719 
AM425 
AM492 
AM484 
AM442 
Region of primary 
mutations 
A 
A 
A 
A 
A 
A 
A 
C 
C 
C 
C 
C 
C 
C 
C 
C 
C 
C 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
Frequency of 
revertants 
4/5000 
6/5000 
0/5000 
3/5000 
6/5000 
7/5000 
2/5000 
2/5000 
5/5000 
10/5000 
6/5000 
0/5000 
0/5000 
6/5000 
2/5000 
0/5000 
2/5000 
3/5000 
7/5000 
0/5000 
2/5000 
9/5000 
0/5000 
7/5000 
5/5000 
10/5000 
6/5000 
0/5000 
6/5000 
0/5000 
1/5000 
Revertants 1 
AM54R 
AM57R 
-
AM399R 
/SiM359R 
AMUIR 
AM141R 
AM166R 
AM326R 
AM49R 
AM753R 
-
-
AM775R 
AM38R 
-
AM152R 
AM429R 
AM342R 
-
AM112R 
AM724R 
-
AM730R 
AM445R 
AM487R 
AM719R 
-
AM492R 
-
AM442R 
(-) not detected. 
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Table 2: The nn/fi candidate reverse intron mutants isolated from EMS treated^t/1 
nrdB double mutant of T4 phage. 
AM54R 
AMlllR 
AM49R 
AM152R 
AM724R 
AM719R 
23 Candidate revertant intron mutants isolated. 
AM57R 
AM141R 
AM753R 
AM429R 
AM730R 
AM492R 
AM399R 
AM166R 
AM775R 
AM342R 
AM445R 
AM442R 
AM359R 
AM326R 
AM38R 
AM112R 
AM487R 
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Table 3 : Marker rescue mapping of the isolated revertants offrdl nrdB double intron 
mutants with pJSSlO clone carrying nrdB gene. 
Revertants 
AM54R 
AM57R 
AM399R 
AM359R 
AMIUR 
AM141R 
AM166R 
AM326R 
AM49R 
AM753R 
AM775R 
AM38R 
AM152R 
AM429R 
AM342R 
AM112R 
AM724R 
AM730R 
AM445R 
AM487R 
AM719R 
AM492R 
AM442R 
Region of 
primary mutations 
A 
A 
A 
A 
A 
A 
C 
C 
C 
C 
C 
C 
C 
C 
D 
D 
D 
D 
D 
D 
D 
D 
D 
MR mapping with pJSSlO 
% frequency of 
halo" plaques* 
56 
60 
80 
20 
40 
24 
40 
20 
-
40 
36 
16 
40 
30 
10 
20 
50 
40 
20 
20 
30 
30 
60 
* Total number of plaque screened, 5000. 
(-) not detected 
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Table 4: The nrdB candidate reverse intron mutants isolated from the EMS treated 
frdl nrdB double mutant exhibited MR^ with pJSSlO clone carrying 
whole nrdB gene. 
AM54R 
AMlllR 
AM753R 
AM429R 
AM730R 
AM492R 
22 Candidate revertant intron mutants that show MR* 
AM57R 
AM141R 
AM775R 
AM342R 
AM445R 
AM442R 
AM399R 
AM166R 
AM38R 
AM112R 
AM487R 
withpJSSlO* 
AM359R 
AM326R 
AM152R 
AM724R 
AM719R 
*AM49R was not mapped with pJSSlO. (Extragenic). 
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Table 5: Marker rescue mapping of the isolated revertants of frd\ nrdB double intron 
mutants with pJBKl clone carrying nrdB intron. 
MR mapping with pJBKl 
Revertants Region of 
primary mutations 
% frequency of 
halo" plaques* 
AM54R 
AM54R 
AM399R 
AM359R 
AMlllR 
AM141R 
AM166R 
AM326R 
AM49R 
AM753R 
AM775R 
AM38R 
AM152R 
AM429R 
AM342R 
AM112R 
AM724R 
AM730R 
AM445R 
AM487R 
AM7I9R 
AM492R 
AM442R 
A 
A 
A 
A 
A 
A 
C 
C 
C 
C 
C 
C 
C 
C 
D 
D 
D 
D 
D 
D 
D 
D 
D 
12 
30 
20 
*Total number of plaque screened, 5000. 
(-) not detected 
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Table 6: The itrdB candidate reverse intron mutants isolated from EMS treated frdl 
nrdB double mutant phage exhibited MR^  with pJBKl clone carrying nrdB 
intron. 
AMlllR 
4 Candidate revertant intron mutants that show MR"^  with pJBKl 
AM429R AM724R AM487R 
l^i 
Table 7: Marker rescue mapping of isolated reverse intron mutants which were 
mapped within the intron with pJG106 clone carrying A+B region of the 
intron. 
Revertants 
AMlllR 
AM429R 
AM724R 
AM487R 
MR mapping with pJG106 
Region of 
primary mutations 
A 
C 
D 
D 
% frequency of 
halo' plaques* 
20 
-
-
-
Mapping position 
of revertants 
A+B 
C+D 
C+D 
C+D 
*Total number of plaque screened, 5000. 
(-) not detected 
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Table 8: Marker rescue mapping of isolated reverse intron mutants which were mapped 
within the A+B region of the intron with pJBSl clone carrying A region of the 
intron. 
Revertant 
AMlllR 
MR mapping with pJBS I 
Region of 
primary mutation 
A 
% frequency of 
halo" plaques* 
10 
Mapping position 
of revertant 
A 
*Total number of plaques screened, 5000. 
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Table 9: Marker rescue mapping of the isolated reverse intron mutants which were 
mapped within the intron with pJGlOS done carrying C+D region of the intron. 
Revertants 
AM429R 
AM724R 
AM487R 
AMIUR 
MR mapping with pJGlOS 
Region of 
primary mutations 
C 
D 
D 
A 
% frequency of 
halo' plaques* 
20 
12 
18 
-
Mapping position 
of revertants 
C+D 
C+D 
C+D 
A 
*Total number of plaque screened, 5000. 
(-) not detected 
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Table 10: Marker rescue mapping of the isolated reverse intron mutants wiiich were 
mapped within the C+D region of intron with pJSK7 clone carrying the D 
region of the intron. 
Revertants 
AM429R 
AM724R 
AM487R 
MR mapping with pJSKT 
Region of 
primary mutations 
C 
D 
D 
% frequency of 
halo' plaques* 
16 
10 
16 
Mapping position 
of revertants 
D 
D 
D 
* Total number of plaques screened, 5000. 
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Table 11: Dot blot splicing assay of the nrtlB revertants aifrdl nrdB mutants oi nrdB 
intron. 
RNA preparation 
of revertants 
ExII ExI-ExII ExI-IVS IVS-ExII Splicing defect 
site 
wt 
AM54R 
AM57R 
AM399R 
AM359R 
AjMlllR 
AiVlHlR 
AJM166R 
AM326R 
AM49R 
AM753R 
AM775R 
AM38R 
AM152R 
AM429R 
AM342R 
AM112R 
AM724R 
AM730R 
AM445R 
AM487R 
.\M719R 
.AJV1492R 
AM442R 
+++ 
+++ 
+++ 
+++ 
+++ 
+ + + 
+++ 
+++ 
+++ 
+++ 
+-H-
+++ 
-h++ 
-H-+ 
+++ 
+ 
+++ 
-t-+ 
4-++ 
++ 
4-
+ 
+++ 
+++ 
+++ 
+ 
+ 
4—r 
5' 
J 
5' 
5' 
5' 
PD(3') 
:> 
^ 
~% t 
:> 
-* t 
3' 
j> 
-* t 
5'&3' 
J 
5' 
5'&3' 
5' 
Hybridization signal : Undetectable, 
Partial Splicing defect. PD 
, Weak, + , Moderate, -*-•-, Intense, 
Table 12 : The salient features of revertants. 
1^6 
Revertants 
AM54R 
AM57R 
AM399 
AM359R 
AMlllR 
AM141R 
AM166R 
AM326R 
AM49R 
AM753R 
AM775R 
AM38R 
AM152R 
AM429R 
AM342R 
AM112R 
AM724R 
AM730R 
AM445R 
AM487R 
AM719R 
AM492R 
AM442R 
Region of 
primary mutation 
A 
A 
A 
A 
A 
A 
C 
C 
C 
C 
C 
C 
C 
C 
D 
D 
D 
D 
D 
D 
D 
D 
D 
Site of reversion* 
Extra intronic 
? 5 
7 ? 
yj 
A 
Extra intronic 
? > 
? > 
Extragenic 
7J 
7 > 
>> 
5 5 
D 
Extra intronic 
7 ? 
D 
Extra intronic 
7 7 
D 
Extra intronic 
7 7 
7 7 
Site of splice defect 
5' 
5' 
3' 
3' 
5' 
5' 
3' 
3' 
5' 
PD(3') 
3' 
3' 
3' 
3' 
3' 
3' 
3' 
3' 
5'&3' 
3" 
5' 
5'&3' 
5' 
"All extra-intronic revertants are intragenic 
frd-
infect£.co/;OK305 
dUMP accumulation^ halo' phenotype 
EMS mutagenesis 
frd -nrdB' '"^ct E. coli 0K3 05^ halo" phenotype 
EMS mutagenesis 
•v 
Second site revertants 
frd- nrdB' 
infect E. coli OK305 
dUMP accumulation -^  halo' phenotype 
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Figure 2: Strategy for the isolation and mapping of intragenic and extragenic 
revertants of nrdB intron mutants. 
Halo* shows that the halo phenotype was clearly visible at minimum fre-
quency of 5% of the plaques screened. Halo' indicates no plaques with halo 
phenotype (or less than 5%). 
I frdlnrdB (holo)| 
• 
EMSmutQgtntsit] 
T 
Mutog*nesi» 
frdlnrdB ps*udor*vertants (hato) 
i 
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Pick»d w*ll isolattd plaqut 
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1 T 
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J_ 
Som* of th* plaqufs or* hol5 
± Intragtnicl 
; 
I M P with pJBKl subclontl 
- — ^ 
[No Rtscut 1 
i 
All ploqut* a r t h a l ^ 
• 
Extragtnic 
Picktd wt l l isolated plaque 
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Bom* of 
_L 
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All a r t halo 
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± T MR with pJ6106 |MR with pJ610e 
i i Mapping 
[Ttsttd for hylS phtnotypt] 
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_L T 
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i i i 
Rttcutd with 
PJBS1 
R t t c u t d with 
PJSR1 
Rttcutd with 
PJSK7 
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Figure 3: Dot blot splicing assay of the revertants of region A of the nrdB 
intron mutants. 
Probes, Exil, EXI-Exll, Exi-IVS, IVS-Exll correspond to Exon il, Splice junc-
tion, Exon l-lntron (5'cutting), and Intron-Exon II (3' cutting) oligonucleotides 
respectively. 
RNAof 
frd\ nrdR 
revertants 
wtT4 
AM54R 
AM57R 
AM399R 
ExII 
• 
• 
• 
• 
Probes 
ExI-ExII ExI-IVS 
M 
m 
m 
m 
• 
• p 
IVS-ExIl 
-
• 
AM359R 
AM111R 
AM141R 
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Figure 4: Dot blot splicing assay of the revertants of region C of the nrdB 
intron mutants. 
Probes, Exil, EXI-Exll, ExI-IVS, IVS-Exll correspond to Exon II, Splice junc-
tion, Exon l-lntron (5'cutting), and Intron-Exon II (3' cutting) oligonucleotides 
respectively. 
RNAof 
frj\ firdR 
revert ants 
\MT4 
Probes 
ExII 
• 
Exl-ExII ExI-IVS 
• 
IVS-ExII 
AM166R 
AM326R 
AM49R 
AM753R 
AM775R 
AM38R 
AM152R 
AM429R 
• m 
t A 
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Figure 5: Dot blot splicing assay of the revertants of region D of the nrdB 
intron mutants. 
Probes, Exil, EXi-Exll. ExI-IVS, IVS-Exll correspond to Exon 11, Splice junc-
tion, Exon 1-lntron (5'cutting), and Intron-Exon II (3' cutting) oligonucleotides 
respectively. ., 
RNAof 
frj\ nrJB 
revertants 
Probes 
ExII EX1-EXII|EXI-IVS IVS-EXII 
wtT4 
AM342R 
AM112R 
AM724R 
AM730R 
AM445R 
AM487R 
AM719R 
AM492R 
AM442R 
W 
0 
•M. 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
m 
ii 
• 
CHAPTER V: General discussion 
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The biochemical and kinetic properties of group I intron auto-catalysis 
have been extensively investigated (Cech, 1990). Self-splicing of pre-mRNA 
in vitro has shown to occur in the absence of proteins or an external source 
of energy; only magnesium and guanosine are necessary. A common splic-
ing mechanism has been demonstrated for several group I introns (Saldanha 
eta), 1993; Wittop-Koning and Schumperii, 1994). The energy requirement 
is obviated by trans-esterification mechanism in vy^ hich the numbers of 
phosphodiester bonds formed and broken are the same. These introns thus 
contain all the structural features necessary for the RNA catalyzed reac-
tions. 
Ability of group I introns to perform autocatalytic splicing has now been 
exemplified by introns originating from phylogenetically diverse organisms. 
The discovery of introns in the T-even phages opened up bacterial genetic 
systems for the analysis of RNA splicing. Although quite different in pri-
mary sequence, a common feature of all group I introns is the presence, in 
a conserved order along the RNA, of several short consensus sequence 
e'ements that exhibit pairwise complementarity and guide folding of a core 
secondary structure that promote catalysis. Four of these elements are 
known as P,Q,R, and S. The internal guide sequence is also complemen-
tary to the 3' border of the 5' exon. 
Additional sequence conservation of group I introns also includes a U 
at the 3' border of exon I and a G at the 3' border of the intron. Several of 
these conserved elements are known to be important because they are sites 
of cis-acting splicing mutations (Tabak and Grivell, 1986). The sequence 
complementarity between pair of elements may allow them to interact to 
form a complex higher order structure, consisting of helical segments, and 
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tertiary structures. This complex structure appears to be essential for splic-
ing activity. These structures have been tested by compensatory mutations 
and by studies with enzymatic methods, chemical probes, NMR spectroscopy 
and computer algorithms (Wang and Cech, 1992; Allain and Varani, 1995 
Gultyaev et al, 1995 ). 
In the present study, taking advantage of phage genetics, we have 
tried to define the most crucial regions of the TA nrdB intron that are criti-
cal to the group I splicing pathway. This was achieved by random 
mutagenesis , without any a pr/or/ knowledge or assumptions about regions 
functional in splicing. Thus by EMS - mutagenesis of the intact phage, and 
isolation and mapping of 156 nrdB mutations, main functional domains of 
the intron were delineated. None of the intron mutetions mapped in its cen-
tral 284 nucleotides stretch, indicating the dispensability of this region to 
splicing. On the other hand, clusters of mutations were mapped to the intron 
border regions, with at least 7 located within 158 nucleotides of the 5' end 
and at least 13 mapping within 143 nucleotides of the 3' end of the intron. 
The intron boundaries might be implicated as its functional splicing ele-
ments. The non-conserved structure is not irrelevent, it could provide a site 
to catalytic residues or to stabilize the overall structure of the intron. Moreo-
ver, it could also provide binding site for proteins that facilitate or regulate 
RNA splicing in vivo (Cech, 1988; Lai and Hall, 1997) as was demon-
strated in certain yeast mitochondrial system (Lazowska et al, 1989; Mohr 
et al, 1992; Coetzee et al, 1994). 
To understand the functional relevance of each sequence in paired 
and unpaired regions, the isolation of pseudo-revertants of nrdB intron mu-
tants, having compensatory mutations vis-a-vis restoring the splicing activ-
ity would be of quite significance. We, therefore, isolated and 
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characterized nrdB intron mutants and their revertants employing f^d^ mu-
tants of T4 phage. Such mutations could also lead to more comprehensive 
understanding of secondary and tertiary interactions for the catalytic activ-
ity of nrdB intron. 
Our study demonstrated that 3' region of ORF in the nrdB intron could 
also play a significant role in the splicing. In contrast, genetic studies on td 
and other group I introns demonstrated that intron ORF is not required for 
the active splicing conformation (Hall et al, 1987). This could probably be 
due to the small size of the ORF of nrdB intron (294 bases) compared to 
that of td intron (778 bases) which are looped out of the secondary struc-
ture models for RNA folding (Waring and Davies, 1984). 
Comparing the dot-blot splicing data of the mutants with their second 
site revertants, we found that by changing the site of reversion, splicing 
defective site has also been changed (Table 18,19,20; Chapter III and Ta-
ble 11; Chapter IV). For instance, mutant AM429 was primarily mapped in 
the region C while after reversion (AM429R) the mapping site has changed 
to lie in the region D (Table 12: Chapter IV). This site of reversion even 
within the short stretch of 239 nucleotides, has reversed the site of defect 
that is from 5' to 3' (Table 19; Chapter III). 
These data suggest the probable involvement of some critical bases 
for integrity of the particular splice junction (5' or 3' cutting site ). 
Present study of the nrdB mutants of phage T4 and their revertants 
further leads us to conclude that the conserved sequences of nrdB intron 
that are important in pre-mRNA splicing, especially the extreme ends of 
nrdB intron, were more critical for autocatalysis. Moreover, the exon 
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sequences immediately adjacent to the splice site were also important for 
splice site selection. Finally, the data also strongly suggest that the cleav-
age of intron might require a well defined secondary structure which on 
folding would probably acquire a typical tertiary structure involving the P9.0 
and P10 loops. These secondary and / or tertiary structures are crucial for 
the splicing of nrcfS intron like other group I type of introns. 
In view of the above discussion, we would like to propose a plausible 
model to show the involvement of various domains of nrdB intron resulting 
in the formation of typical tertiary structure (Fig. 1). 
The ORF region and neighbouring conserved region of P4-P6 domain 
stabilize the RNA structure essential for splicing. The catalytic core is formed 
by the folding of P1-P3 and P7-P9 domains. A conserved adenine in the 
catalytic core contributes to the stability of this arrangement and accepts a 
hydrogen bond from a specific 2'-0H of the P1 pairing region. Such back-
bone tertiary interactions might generally be important to the organization 
of RNA tertiary structure (Pyle et al, 1992). 
This hypothetical model for the autocatalysis of nrdB intron is very 
close to that proposed earlier in case of Tetrahymena intron ( Doherty and 
Doudna, 1997). 
1J6 
Figure 1: A proposed model for tertiary structure of nrdB intron involved in 
self splicing. 
Solid lines show connectivities with each RNA domain while dashed lines 
indicate connectivities within the intact intron. Arrows superimposed on 
lines give 5' to 3' polarity. The 5' and 3' exon sequences are shown in lower 
case letters and both the sites are marked with arrows. Base-paired seg-
ments are designated as "P" and sections that join the two paired regions 
as "J". 
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SUMMARY 
1 
The nrdB gene of bacteriophage T4 codes for a small subunit of 
ribonucleotide reductase and contains 598 base-pair self splicing intron 
which is closely related to group I introns of T4 and eukaryotes. The strat-
egy for isolation and mapping of EMS-induced splicing defective mutants 
within the intron of nrdB gene was based upon the appearance/disappear-
ance of halo* phenotype on GPTG medium. Halo* or white halo phenotype 
implies is the excessive bacterial growth around the plaque due to the ac-
cumulation of uracil in f^d^ mutants of T4 phage on infection to the OK305 
strain of Eco// which is defective in its pyrimidine metabolism. Using this 
novel technique we have isolated a total of 432 EMS-induced frd^ double 
mutants (halo')which were further mapped within the nrdB gene by using 
marker rescue technique with the clone pJSSIO carrying the whole nrdB 
gene. A total of 156 mutants were mapped within the nrdB gene. The finer 
mapping of these 156 mutants was carried out by marker rescue technique 
with the pJBKI clone and various subclones of nrdB intron. It was found 
that out of 31 intron mutants, 7 were mapped within the A region at the 
5'end of intron, 11 were found to map within C region and remaining 13 
were clustered near the 3'end of intron in the region D. None of the muta-
tions was mapped in the region B which is having a non-conserved se-
quence. 
The dot-blot splicing assay was performed to analyse splicing defec-
tive point mutations within the nrdB intron of bacteriophage T4. End-la-
belled DNA probes were designed such that their bindings were dependent 
on the splicing of the nrdB intron. Four DNA probes were used in this splic-
ing assay. The wild type T4 RNA preparation was used as positive control 
to measure the splicing proficiency. 
The present study led us to conclude the following: 
(1) The conserved sequences In the nrdB intron like td and other group I 
introns were important in pre-mRNA splicing. 
(2) The 5' and 3' domains of nrdB Intron were more critical for splicing, 
especially the 3' end at which most of the splicing defective mutations were 
clustered. 
(3) None of the mutations was found within the B region of nrdB intron 
which is outside the conserved P, Q, R, and S sequences. 
(4) Dot-blot splicing assay suggested that all the mutations within the intron 
of nrdB gene were splicing defective and their defects were either at the 
5'cutting site or at 3' cutting site, some of them have shown the defects at 
both the cutting sites. Interestingly, some of them were found to be only 
partially splicing defective. 
(6) Exon sequences those immediately adjacent to the splice site were also 
important for splice site selection in splicing. 
(6) ORF region of nrdB intron could also play an important role in the splic-
ing of intron. The absence of the conserved region might imply that some 
sort of tertiary interactions between ORF and neighbouring conserved re-
gions are involved to stabilize the RNA structure essential for splicing. 
(7) It is clear from studies on nrdB intron that, it is a self splicing group I 
type Intron with a core catalytic structure similar to other introns of Its group. 
In the second part of this study we isolated intragenic and extragenic 
revertants of our f^d^n^dB double mutants of bacteriophage T4. These 
second site revertants were again obtained by EMS-induced mutagenesis. 
The basis of selection of these mutants was the inversion of the halo phe-
notype from hale to halo* character. We have been able to isolate 23 
revertants amongst them only one was found to be an extragenic. The iso-
lation and mapping of these revertants were performed, similarly as was 
previously done in the case of splicing defective point mutations. The map-
ping results revealed that only 4 out of 22 intragenic' reversions located 
vkrtthin or near the intron of nrdB gene whereas remaining were probably 
either within the exon or near the ends of the exon I and exon II, i.e. the 
intron-exon junction. Further mapping of these four revertants within the 
intron was carried out by the usage of marker rescue technique with vari-
ous sub-clones of intron. Out of 4 revertants, three were found to map near 
the primary mapping positions whereas one was mapped in the D region 
though, primarily it was mapped in the C region of intron. 
The dot blot splicing assay was also performed with the same probes 
used as described earlier. It revealed that all the intragenic and extragenic 
revertants were found to be splicing defective except one intragenic revertant 
which was found to compensate the effect of its primary mutation whereas 
the isolated extragenic revertant could not restore splicing proficiency. 
These findings are suggestive of the following reasons: 
(1) Most of the nrdB intragenic revertants were not mapped within the intron 
probably because, these mutants might be present on either extreme ends 
of intron or adjacent to the intron i.e. the end of exon I or start of exon i l. 
Whereas the extragenic revertant that lies outside the nrdB gene would 
probably disrupt the pyrimidine biosynthesis pathway resulting in the white 
halo phenotype. 
(2) One intragenic suppressor mutant was detected as partially splicing pro-
ficient and hence this second site revertant would have been able to re-
store splicing activity of AM753 mutant to some extant. 
(3) One revertant out of 23 was found to be extragenic. This second site 
mutation could not restore the splicing defect perhaps owing to a second 
mutation within the frd gene leading to accumulation of dUMP and thus pro-
ducing weak halos by compensating for the effects of leaky nrdB mutation. 
This extragenic revertant did not affect splicing of nrdB RNA, but affected 
the halo phenotype. 
(4) Mapping and dot-blot splicing assay suggested that the cleavage of the 
intron might involve a well defined secondary structure which on folding 
would probably attain a typical tertiary structure. These secondary and / or 
tertiary structures are crucial for the splicing of nrdB intron like other group 
I type introns. 
